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Abstract 
 
Group B Streptococcus or GBS (also referred as Streptococcus agalactiae) is a 
Gram-positive human pathogen representing one of the most common causes of 
life-threatening bacterial infections such as sepsis and meningitis in neonates and 
infants. Covalently polymerized pilus-like structures have been discovered in 
GBS as important virulence factors as well as vaccine candidates. Pili are protein 
polymers that form long and thin filamentous structures protruding from bacterial 
cells, mediating adhesion and colonization to host cells and other activities 
involved in the virulence of the bacterium. Gram-positive bacteria, including GBS, 
build pili on their cell surface via a class C sortase-catalyzed transpeptidation 
mechanism from pilin protein substrates that are the backbone protein (BP) 
forming the pilus shaft and two ancillary proteins (APs). Also the cell-wall 
anchoring of the pilus polymers made of covalently linked pilin subunits is 
mediated by a sortase enzyme. GBS expresses three structurally distinct pilus 
types (type 1, 2a and 2b). Although the mechanisms of assembly and cell wall 
anchoring of GBS types 1 and 2a pili have been investigated, those of pilus 2b are 
not understood until now. Pilus 2b is frequently found in ST-17 strains that are 
mostly associated with meningitis and high mortality rate especially in infants. 
In this work the assembly mechanism of GBS pilus type 2b has been elucidated 
by dissecting through genetic, biochemical and structural studies the role of the 
two pilus-associated sortases. The most significant findings show that pilus 2b 
assembly (in terms of pilin subunits polymerization and cell-wall anchoring of the 
pilus polymers) appears “non-canonical”, differing significantly from the current 
model of pilus assembly in Gram-positive pathogens. Only one pilus-related 
sortase (SrtC1-2b) is involved in pilin polymerization, while the second sortase 
(SrtC2-2b) does not act as a pilin polymerase, but it is involved in cell-wall pilus 
anchoring by using the minor ancillary subunit as anchor protein. Our findings 
provide new insights into pili biogenesis in Gram-positive bacteria. Moreover, the 
role of this pilus type during  host infection has been investigated. By using a 
mouse model of meningitis we demonstrated that type 2b pilus contributes to 
pathogenesis of meningitis in vivo.  
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Chapter 1. Introduction 
1.1 Streptococcus agalactiae (Group B Streptococcus, GBS) 
 
Group B Streptococcus or GBS (also referred to as Streptococcus agalactiae) is 
an encapsulated Gram-positive bacteria. It generally grows in pairs or in long 
chains of spherical bacteria, less than 2 m in size (Fig. 1A). It displays beta-
hemolysis when cultured on blood agar plates and produces zones of hemolysis 
that are only slightly larger than the colonies themselves (Fig. 1B) (1). GBS 
strains are classified into ten serotypes according to immunogenic characteristics 
of the capsule polysaccharides that surround its surface (Ia, Ib, II, III, IV, V, VI, 
VII, VIII and IX) (2). Approximately, 10% of serotypes are non-typeable (3). 
 
Figure 1. Streptococcus agalactiae. (A) Scanning Electron Microscopy (SEM) of 
Streptococcus agalactiae. (B) Colonies of Streptococcus agalactiae on a blood agar plate. 
Note the zone of clear haemolysis. 
 
 Consistent with other streptococcal species, Streptococcus agalactiae is present 
on the mucosal surfaces of animals and humans (4). In fact, GBS can usually 
colonize asymptomatically as a normal commensal the intestinal and 
genitourinary tract but also the pharyngeal mucosa of human healthy adults (5,6) 
and 20–40% of healthy women carry GBS (5,7,8). GBS can also cause serious 
bacterial infections in newborns and young infants leading to pneumonia, sepsis 
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and meningitis. To cause meningitis GBS has to interact and penetrate the blood-
brain barrier (BBB) to gain access to the central nervous system (CNS). The BBB 
is mainly composed by a monolayer of specialized human brain microvascular 
endothelial cells (hBMEC), and it separates the brain from the circulating blood, 
thus regulating the flow of nutrients and also preventing circulating bacteria to 
permeate it (9,10). GBS has many surface virulence factors important for host 
infection and among them, pili have been recently implicated in mediating 
attachment to many different human epithelial cells (11), and among them also to 
brain microvascular endothelial cells (12). 
GBS is not only one of the most common causes of life-threatening bacterial 
infections in neonates, but can cause severe infections in elderly and immune-
compromised patients (13,14). Moreover Streptococcus agalactiae is also 
associated to a number of postpartum sequelae, such as urinary tract infections, 
amnionitis and endometritis (15). 
 
 
Figure 2. GBS cause serious bacterial infections in newborns and young infants. 
GBS commensal colonization of the rectovaginal tract of 10-30% of healthy women can 
be the cause of the 50-70% of children that will become colonized after delivery. The 
infection incidence is 1 out of 1200 live births per year. 
 
GBS disease in newborns has been divided in early-onset disease (EOD) and late-
onset disease (LOD) depending on the infants’ age and disease manifestation. 
Early-onset disease manifests in the first week of life and the neonate is usually 
infected by exposure to GBS during birth. The transmission from mothers to 
newborns usually occurs when the neonate aspirates contaminated amniotic and 
vaginal fluids before or during delivery (16). Early-onset disease can progress as 
11 
 
pneumonia and the bacteria can spread into the bloodstream resulting in septi-
caemia, meningitis and osteomyelitis (17-19).  
Infants who present late-onset disease do not show signs of infection in the first 6 
days of life. LOD (7–90 days) is less frequent than EOD and the mortality rate is 
lower but morbidity is high, as around 50% of neonates that survive to GBS 
infection suffer complications, including mental retardation, hearing loss and 
speech and language delay (15,18,20).  
Vaccination represents the most attractive strategy for GBS disease prevention. 
Effective vaccines would stimulate the production of functionally active 
antibodies that could cross the placenta and provide protection against neonatal 
GBS infection. During the last years, polysaccharide-based vaccines against GBS 
have been extensively studied, but also several promising protein antigens have 
been identified leading to the potential development of universal protein-based 
vaccines (21-24).  
 
 
1.1.1 The hypervirulent clone ST-17 
 
Population genetics methods have been applied to GBS strains to investigate 
genotypes associated with disease, assess genetic variation within genotypes, and 
examine the role of recombination in the generation of new genotypes. Several 
methods have identified specific GBS genotypes to be associated with neonatal 
disease. Multilocus sequence typing (MLST), which uncovers sequence variation 
among conserved housekeeping genes, has classified GBS strains into numerous 
clones, or sequence types (STs) (25). In this system, fragments (459 to 519 bp) of 
seven housekeeping genes are amplified by PCR for each strain and sequenced. 
The combination of alleles at the seven loci provided an allelic profile or sequence 
type (ST) for each strain. The majority of analyzed isolates causing neonatal 
diseases belongs to the ST-17 clone and is serotype III. This ST appeared to be 
associated with the late-onset disease (LOD) and meningitis in infants after the 
first week of life (26,27) (25). So the ST-17 serotype III strains were defined 
“highly virulent” clones since they were strongly associated with neonatal 
invasive infections (28) as reported from studies performed in Canada (29), in 
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Israel (30), Sweden (31), the United Kingdom (32), Portugal (33), France (34) and 
the United States (35). 
By following phylogenetic analyses STs were grouped together into clusters or 
clonal complexes (CCs) and seven clusters have been identified to include the 
majority of the circulating clinically relevant GBS strains (30,36). The distribution 
of CCs has been shown to vary in colonizing and invasive strains (30,32,35,36). 
Different genomic studies showed that the ST-17 hypervirulent clone is a 
homogeneous group of strains that displays a conserved combination of 
secreted/surface proteins, including the pilus type 2b (37). 
 
1.1.2 Identification of novel genomic islands coding for pilus-like structures in 
Streptococcus agalactiae  
 
In the last decade, the exponential growth of genome sequence information has 
led to the identification in several Gram-positive organisms, including GBS, of 
covalently polymerized pilus-like structures that were remained largely unknown 
until then. Pili are protein polymers that form long and thin filamentous structures 
extending out from the bacterial cells, mediating adhesion and colonization to host 
cells, biofilm formation or other activities involved in the virulence/pathogenesis 
of the bacterium (38,39). Moreover, pili contribute to BBB penetration and 
meningitis development (40). It has been reported that these surface structures are 
involved in GBS adhesion and invasion of the host. Specifically, pili mediate the 
initial bacterial attachment to the host, binding to extracellular matrix (ECM) 
components and thus facilitating the bacterial uptake by host cells (41,42).  
Additionally, a recent study provided evidence for an active role of S. agalactiae 
pilus proteins in the paracellular translocation through the epithelial barrier, 
during host colonization (43). Gram-positive pili could be considered important 
virulence factors for several diseases (44), in particular infections of the urinary, 
genital and gastrointestinal tracts and particularly in GBS they have been 
identified as promising vaccine candidates (23,24,45).  
In 2005, characterization studies of protective antigens by a multiple genome 
approach aiming at the development of an effective vaccine against GBS 
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infections, revealed for the first time in a streptococcal species the existence of 
high-molecular-weight (HMW) polymers, visible by electron microscopy as pilus-
like structures extending out from the bacterial surface (6;11;12).  
Subsequently, comparative analysis of the eight published genome sequences 
have permitted the discovery in GBS of three genomic pilus islands (PIs), named 
PI-1, PI-2a and PI-2b (13). The overall organization of the three islands is similar 
to pilus gene clusters identified in other Gram-positive bacteria (9;14) (Fig. 3). 
Each of the GBS PIs encodes three structural pilus components, corresponding to 
the major pilus subunit (known as the backbone protein, BP) forming the pilus 
shaft and the two ancillary proteins (named ancillary protein 1, AP1 and ancillary 
protein 2, AP2). These structural subunits harbour a (L/I)PXTG sorting motif  that 
is typical of cell wall-anchored proteins. In addition, the pilus clusters contain at 
least two genes coding for pilus-associated class C sortase enzymes (SrtC1 and 
SrtC2) catalyzing pilus protein polymerization (11;13).  
PI-1 consists of an approximately 16 kbp-long DNA region flanked by 11 bp of 
direct repeats, and it has been found in ≈ 70% of the GBS strains that have been 
analyzed (24,46). In addition to the pilus genes, the genomic island contains a 
gene that encodes an AraC-type transcriptional regulator (Fig. 3A). 
PI-2a and PI-2b represent two variants of Pilus Island 2 since they are 
alternatively present in the same genomic locus and define an approximately 11 
kb region flanked by identical conserved genes. In addition to the genes coding 
for the three pilus structural subunits and two sortases, upstream of the ap1 gene, 
the PI-2a region contains a gene coding for a rogB type transcriptional regulator 
(15). PI-2b lacks the transcriptional regulator but contains a gene that encodes for 
a protein similar to the LepA-type signal peptidase of Gram-negative bacteria (Fig. 
3B). 
The three pilus islands in GBS are similar in organization but poorly conserved 
among different isolates. Extensive genome analysis of pili distribution and 
conservation in large collection of GBS clinical isolates showed that all strains 
analyzed carried at least one of the islands, and 94% of these isolates expressed 
pili on their surface (24). In particular PI-1 is never found alone, but always in 
combination with one of the two variants of PI-2 (47).  
Interestingly, a correlation was observed between the presence of a particular 
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combination of PIs and the capsule (CPS) type. All serotype III isolates (the most 
epidemiologically relevant serotype) carried a combination of two pilus islands: 
30% of the strains contained PI-1 and PI-2a, while 70% carried PI-1 and PI-2b. 
Moreover, the highly virulent sequence type 17 (ST-17) seemed to be strongly 
associated with PI-1 plus PI-2b pattern (37(48,49)) suggesting the importance of 
this pilus type in bacterial virulence. 
 
 
 
 
Figure 3. Schematic representation of GBS pilus-island regions. A) pilus island 1; B) 
pilus island 2. Genes coding for LPXTG-containing proteins are represented with orange 
arrows, whereas transcriptional regulators are in green and conserved flanking genes are 
in grey. At least two sortases are present in each PI (black arrows), while a signal 
peptidase is present in PI-2b (yellow arrow). For PI-1 and PI-2a, gene numbers are 
relative to the database annotation for strain 2603 V/R, while for PI-2b, gene numbers are 
relative to COH1 strain. DR: direct repeat (50). 
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1.2 Structure and assembly of Gram-positive pili 
 
The best-known and characterized pili are those of Gram-negative bacteria: the 
Type I and Type P pili of Escherichia coli, and the Type IV pili of Neisseria 
species (51), which form rod-like bundles of non-covalently assembled subunits. 
In contrast, the pili on Gram-positive bacteria are basically different. They are 
long (2–5 µm) but extremely thin (about 3 nm), assembled by enzymes called 
sortases, and they are exceptional examples of covalent polymers (Fig. 4).  
 
 
Figure 4. Different examples of pilus-like structures in Gram-negative and Gram-
positive bacteria. Electron micrographs of fimbriae in Gram-negative organisms : E. coli 
(A) and Salmonella enterica (B). Electron microscopy of two different types of pili in 
Gram-positive bacteria: fibrils in Streptococcus salivarius (C) and pili in Streptococcus 
agalactiae (D) stained by immunogold labeling (52).  
 
Despite many years of studies on Gram-positive bacteria, their pili remained 
largely ignored until very recently (53). The identification and the characterization 
of pilus structures in different Gram-positive microorganisms in a very short time 
(from 2005 to date) represent an example of the amazing impact of genomics in 
accelerating the discovery of previously unknown functions. (53). Pili can be 
visualized on the bacterial surface by negative staining, or, more specifically, by 
immunogold electron microscopy (IEM), which can reveal the localization of a 
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protein within the pilus structure using pilin specific antisera (Fig. 5B-D-F). 
Gram-positive pili are composed of multiple copies of a single pilin called 
backbone protein (BP), and of other two additional proteins associated with the 
shaft (called major and minor ancillary proteins).  
However, the expression of pilus structures can be generally detected by 
immunoblot assays using total cell proteins separated by SDS-PAGE and probed 
with antisera anti pilin subunit. A protein that is part of a pilus will appear as a 
high molecular weight (HMW) ladder (Fig. 5A-C-E).  
The backbone protein has been demonstrated to be very important for pilus 
polymerization and function. Indeed it has been reported that no pilus structures 
can be detected on the bacterial cell surface if the BP gene is deleted, suggesting 
the backbone protein is required for incorporating other two ancillary proteins into 
the pilus structure (50). In fact antisera specific for the backbone protein stain the 
whole length of the pilus structure (52), while, antisera specific for ancillary 
protein 1 (AP1) detect this pilin subunit at the pilus tip and along the pilus shaft 
(50). The minor ancillary pilus component, AP2, is thought to be the terminal 
pilus subunit, located at the pilus base (54) (55). Ancillary proteins (APs) are not 
required for backbone protein polymerization but might function as adhesins or in 
anchoring to the cell wall (55). 
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Figure 5. GBS PI-1, 2a and 2b pili. (A) Immunoblots of total protein extracts from GBS 
JM9130013 strain probed with antisera specific for PI-1 proteins GBS80 (α-80), GBS104 
(α-104) and GBS52 (α-52). (B) Immunogold labeling and transmission electron 
microscopy of GBS80 in strain JM9130013, showing long pilus-like structures.(C) 
Immunoblots of total protein extracts from GBS 515 strain probed with antisera specific 
for PI-2a proteins GBS59 (α-59), GBS67 (α-67) and GBS150 (α-150). Asterisks (*) 
indicate the monomeric form of GBS59, GBS67 and GBS150. (D) Immunogold electron 
microscopy of 515 strain incubated with sera raised against GBS59 protein and labeled 
with secondary antibodies conjugated with 10nm gold particles. (E) Immunoblots of total 
protein extracts from GBS JM9130013 strain probed with antisera specific for PI-2b 
proteins SAN1518 (α-1518), SAN1519 (α-1519) and SAN1516 (α-1516). (F) 
Immunogold electron microscopy of JM9130013 wt strain incubated with sera raised 
against GBS1518  protein and labeled with secondary antibodies conjugated with 10nm 
gold particles (50). 
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The three pilus proteins together with genes coding for sortases, that are required 
for pilus assembly, are encoded in a small gene cluster within pathogenicity 
islands which are known as Pilus Islands (PIs). The genes are transcribed in the 
same direction, indicating that they are part of an operon. The three pilus 
components are characterized by the presence of an N-terminal signal peptide 
together with a C-terminal cell-wall sorting signal (CWSS) that is found in many 
surface proteins and is required for the attachment to the peptidoglycan of the cell 
wall. The CWSS comprises the amino acid sequence “LPXTG” (where X denotes 
any amino acid) or a variation of this motif followed by a hydrophobic 
membrane-spanning domain and a positively charged tail.  
This motif is targeted by sortase enzymes, which are membrane-bound 
transpeptidases catalysing the covalent linkage of LPXTG motif proteins. During 
pilus formation, specific pilus-related sortases catalyse the covalent attachment of 
the pilin subunits to each other or to the peptidoglycan cell wall (52).  
The first insights into the assembly mechanism of Gram-positive pili were 
provided by a study performed on Corynebacterium diphteriae (50, 60). 
Initially, the three pilus components containing an LPXTG motif are secreted in a 
Sec-dependent way (52). Each component remains anchored to the cell membrane, 
owing to the presence of the C-terminal hydrophobic transmembrane domain. 
The second step involves a sortase-dependent reaction in which the membrane-
anchored proteins are cleaved at the LPXTG motif, between the threonine (T) and 
glycine (G) residue. This reaction leads to the formation of acyl-enzyme 
intermediates in which a covalent thioester bond is formed between the thiol 
group of the cysteine residue located in the catalytic pocket of the sortase and the 
carboxyl group of the threonine residue in the LPXTG motif of the pilin protein 
(52). Because sortases are membrane-associated enzymes, the acyl-enzyme 
derivatives that are formed are retained on the external side of the membrane (Fig. 
6). 
The following steps of the assembly process involve the oligomerization of the 
pilus protein subunits and the anchoring of the oligomerized structure to the cell 
wall. 
These steps require the nucleophilic attack of the thioester bond in the acyl-
enzyme intermediate. During pilus polymerization the nucleophile is provided by 
19 
 
the ε-amino group of a specific lysine (K) residue within the “pilin motif”, 
WXXXVXVYPKN (where X denotes any amino acid), which has been found in 
most of the pilin subunits that have been characterized (55).  
The nucleophilic attack results in cleavage of the thioester bond and concomitant 
formation of an amide bond between the carbonyl-group carbon of the threonine 
residue of the pilin subunit (present in the catalytic pocket of the sortase) and the 
lysine side-chain (ε-amino group) of the pilin motif of the neighboring pilin 
subunit. This leads to the formation of a membrane-associated covalently linked 
dimer with a pilin motif that can interact with other sortase- associated pilin 
subunits, forming an elongated pilus fiber.  
According to this model, pilus growth occurs by subunit addition at the base of 
the pilus (Fig. 6), and the length of the pilus depends on the relative abundance of 
the pilus subunits that are coupled to the membrane-associated sortases (52). 
Finally, the association of the membrane-proximal pilus subunit with the cell wall 
occurs when the thioester bond between the subunit and the sortase is subject to 
nucleophilic attack by the amino group in the cross-bridge of the peptidoglycan 
precursor lipid II (56), and this leads to the formation of an amide bond between 
the basal subunit and the bacterial cell wall.  
In conclusion, pilus assembly in Gram-positive bacteria seems to occur by a 
universal mechanism of ordered cross-linking of precursor proteins, whose 
multiple conserved features are recognized by designated sortase enzymes (55,57).  
Also GBS pili are covalently linked structures that follow this biphasic assembly 
mechanism (58). SortaseC-polymerized backbone protein (BP) units constitute the 
pilus scaffold and ancillary proteins 1 and 2 are located respectively at the tip and 
the base of the pilus. Polymerized pili are anchored to the cell wall by the 
housekeeping sortase A (SrtA) and protrude from the bacterial cell surface. No 
detectable role in pilus polymerization for the housekeeping SrtA was found in 
GBS (50,59). 
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Figure 6. General model for pilus assembly in Gram-positive bacteria (52). (A) In the 
first step, proteins that contain the amino-acid motif LPXTG are targeted to the cell 
membrane by Sec-dependent secretion (not shown). This is followed by a sortase-
mediated reaction (indicated by the arrows) in which the LPXTG motif is cleaved 
between the threonine (T) and glycine (G) residues. (B) The reaction leads to the 
formation of an acyl-enzyme intermediate in which a covalent thioester bond is formed 
between the thiol group of a cysteine residue in the sortase and the carboxyl group of the 
pilin threonine residue. (C) Oligomerization occurs after the nucleophilic attack provided 
by the e-amino group of the lysine residue in the pilin motif on the cysteine residue of the 
sortase. (D)The thioester bond between the pilin subunit and the sortase is targeted by the 
amino group of the pentapeptide of lipid II, the precursor of peptidoglycan. (E) This leads 
to the formation of an elongated pilus covalently linked to the cell wall peptidoglycan. 
NAG, N-acetyl glucosamine; NAM, N-acetyl muramic acid (52). 
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1.3 Sequence and structure of pilin subunits 
 
The current model proposed for pilus assembly in Gram-positive bacteria as 
already described above, is based on a transpeptidation mechanism of pilins (58). 
Sortases recognize specific sequence elements and/or residues in the pilin subunit 
that are essential for pilus assembly, and well conserved among pilin-subunits in 
different bacteria. Briefly, these main motives include: 
 
 the pilin motif (consensus WxxxVxVYPK), wherein the lysine residue (K) 
participates in sortase-catalysed amide bond formation by reaction with 
the C terminus of the next subunit molecule during polymerization; 
 a cell wall sorting signal (CWSS) containing the sortase recognition site 
LPxTG motif, typical of cell wall-anchored proteins; 
 the E-box motif (consensus YxLxETxAPxGY), important for the proper 
folding of pilin proteins and subsequently necessary for pilus 
polymerization (60-62). Moreover, several X-ray crystal structures of 
backbone pilins have shown that a specific E-box residue is involved in 
the formation of intramolecular isopeptide bonds and that these linkages 
confer higher stability to the monomeric subunit (63-65). 
 
Despite low sequence similarities, pilin subunits of Gram-positive bacteria show 
very similar tridimensional structure comprising immunoglobulin G (IgG)-like 
domains of shared evolutionary origin. These domains are all stabilized by 
intramolecular isopeptide bonds commonly formed by Lys-Asn residues (although 
Lys-Asp bonds also exist) located in a largely hydrophobic pocket comprising 
several aromatic residues, including a bond-catalyzing aspartyl or glutamyl 
residue.  
Intriguingly, in the backbone protein of GBS pilus 2a (BP-2a) and in other major 
pilins this glutamate is the same conserved residue present in the E-box motif 
(50,62).  
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Figure 7. Comparisons of BP-2b with other pilus backbone proteins. A) The structure 
of BP-2b is depicted with light blue and orange cartoons for domains D2 and D3. B) BP-
2b (blue cartoon) is shown overlaid onto: the pilus backbone protein RrgB (pdb 2x9x, red 
cartoon, left), the major pilin protein GBS80 (GBS-PI-1) (pdb 3pf2, green cartoon, 
middle), and on the major pilin protein BP-2a (pdb 2xtl, pink cartoon, right). C) Primary 
sequence alignment of BPs of the three PI in GBS. 
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In recent years, the X-ray crystal structures of several Gram-positive pilin proteins 
from Corynnebacteium diphtheriae (66,67), Actinomyces species (68,69), 
Streptococcus pyogenes (65), Streptococcus pneumoniae (70-74), Streptococcus 
agalactiae (45,75-77) and Bacillus cereus (78) have been described.  
Also BP-2b X-ray structure was solved encompassing domains D2 and D3 (Fig. 
7A). Both domains revealed an IgG-like fold organization, typical of the pilin 
subunits, and the presence of internal isopeptide bonds in each domain. 
Nevertheless, except for the typical C-terminal cell wall sorting signal BP-2b does 
not contain the canonical conserved primary sequence motives described for pilus 
polymerization in Gram-positive bacteria, suggesting a different mechanism of 
assembly of this pilus type. BP-2b indeed does not harbor a canonical E-box 
domain neither a conserved pilin motif (Fig. 7C). 
 
1.4 Sortase enzymes in Gram-positive bacteria 
 
Sortases are a family of membrane-associated enzymes, known especially to 
catalyze the covalent anchoring of surface proteins to the cell wall envelope in 
Gram-positive bacteria (79,80). These enzymes are cysteine transpeptidases, 
which recognize a conserved carboxylic CWSS followed by a hydrophobic stretch 
of amino acids and a short positively charged tail (57,80,81).  
Sortases are positioned at the cytoplasmic membrane via a membrane anchor 
located either at the N- or C-terminus, contain the active site, LxTC motif (80), of 
which cysteine is essential for the sortase activity (82) and recognize their 
substrate proteins via a common C-terminal pentapeptide sequence, which acts as 
a cell wall sorting signal. So far, more than 700 putative sortase substrates 
encoded by more than 50 different prokaryotic genomes have been identified (83). 
Although they are not essential for bacterial viability when cells are grown in rich 
media, sortases can be important virulence factors as they display surface proteins 
that mediate bacterial adhesion to host tissues, host cell entry, evasion and 
suppression of the immune response and acquisition of essential nutrients.  
Multiple sortases are often found in the same genome in different bacterial species 
and can be grouped into six classes based on their primary sequences, membrane 
topology, genomic localization, and specificity for amino acid sequence motifs 
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(84,85). These six families include class A to F enzymes (Fig. 8) (84) (11). 
Experimental and bioinformatics analyses indicate that members of each group 
recognize distinct CWSSs in which the LPXTG sequence is diverse (hereafter 
called sorting signal motifs).  
 
 
 
 Figure 8. Phylogenic tree showing the relationships among the six classes of sortases 
from Gram-positive bacteria. A multiple sequence alignment based on pairwise 
constraints of a selected set of 73 sortase proteins was generated using the program 
COBALT and a phylogenetic tree constructed using the neighbour joining method (86). 
The analysed sortases can be partitioned into six distinct subfamilies based on their 
primary sequences. It should be noted that the class D and E enzymes described here are 
collectively referred to as a class D enzymes by Bierne and colleagues (85). Class D and 
E enzymes have also previously been referred to as subfamily-4 and -5 enzymes (84). The 
bacterial species associated with the enzyme classes A–F are listed and schematic 
representations of the main biological function of their corresponding sortase substrates 
are illustrated (79). 
 
Class A enzymes appear to perform a housekeeping role in the cell as members of 
this group are able to anchor a great number of functionally different proteins to 
the cell wall. The sorting reaction catalyzed by the sortase A protein from 
Staphylococcus aureus (SrtA) is the best understood and begins when a full-
length precursor protein containing an amino terminal leader peptide is exported 
from the cytoplasm through the secretory pathway. The C-terminal CWSS is then 
processed by SrtA. The C-terminal charged tail presumably retards export, 
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positioning the protein for processing by the extracellular membrane associated 
SrtA enzyme. Then a highly conserved active site cysteine residue in SrtA 
nucleophilically attacks the backbone carbonyl carbon of the threonine residue in 
the LPXTG motif, breaking the threonine and glycine peptide bond and creating a 
sortase-protein complex in which the components are linked via a thioacyl bond. 
The protein is then relocated by SrtA to the cell wall precursor lipid II, when the 
amino group in this molecule nucleophilically attacks the thioacyl linkage to 
create an isopeptide linked protein-lipid II product. Transglycosylation and 
transpeptidation reactions synthesize the cell wall and then incorporate this 
product into the peptidoglycan, where it is covalently linked to the cross-bridge 
peptide. Other sortases catalyse a similar transpeptidation reaction, but join 
remarkably different LPXTG motifs and amino groups.  
Most surface proteins attached by class A enzymes contain a canonical LPXTG 
motif within their CWSS and have diverse functions that can promote bacterial 
adhesion, nutrient acquisition, host cell invasion, and immune evasion.  
Class A enzymes have attracted significant interest as potential drug targets 
because a number of clinically important pathogens use these sortases to display 
virulence factors and they are attenuated in their virulence if their srtA gene is 
eliminated (S. aureus, L. monocytogenes, Streptococcus pyogenes and 
Streptococcus pneumoniae among others) (87) (88). 
Class B enzymes can have distinct functions. Some members of this group attach 
haem-receptors to the peptidoglycan, while others assemble pili especially during 
iron starvation conditions.  
Class C enzymes are broadly distributed in Gram-positive bacteria and function as 
pilin polymerases that construct pili.  
Class D enzymes predominate in Bacilli and in Bacillus anthracis; this type of 
enzyme anchors proteins to the cell wall that facilitate sporulation.  
Actinobacteria contain class E and F enzymes whose functions are largely 
unknown. In Corynebacterium diphtheriae a class E enzyme appears to perform a 
housekeeping function similar to class A enzymes (55), while class F enzymes 
have yet to be studied.  
Sortases are also present in a few Gram-negative and archaebacterial species, but 
the functions of these enzymes are still unknown (84,89,90). 
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1.4.1 Class C sortases  
 
The class C sortases, also called pilus-specific sortases, represent the biggest and 
most heterogeneous group of enzymes and are encoded by genes clustered 
together with the genes coding for the pilus structural subunits in genomic islands 
inserted in specific loci of the genome. The overall organization of these pilus 
islands is similar among Gram-positive bacteria.  
In GBS, sequence comparison by multiple alignment and phylogenetic analysis 
allowed the identification of 3 major clusters, corresponding to class C sortases of 
PI-1, PI-2a, and PI-2b, with amino acid identities ranging from 15 to 60% (Fig. 9).  
 
 
Figure 9. Class C sortases in PIs of GBS. (A) Schematic representation of GBS PIs. (B) 
Phylogenetic tree inferred from the alignment by the neighbor-joining distance-based 
method of C sortases from the available genomes of GBS. Single sortases are indicated 
by TIGR annotation. The 3 major clusters, highlighted in the boxes, include C sortases of 
each PI (91). 
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Although the assembly mechanism and cell wall anchoring of GBS type 1 and 2a 
pili have been investigated, those of pilus type 2b are not understood. In GBS 
pilus 1 and 2a two class C sortases (SrtC1 and SrtC2) are involved in the pilin 
proteins polymerization and the assembly mechanism occurs following the 
classical biphasic model (56).  
Genetic studies showed that (50) SrtC1 and SrtC2 from pilus 1 and 2a can both 
efficiently polymerize the backbone proteins and were found to be specific in 
terms of ancillary proteins incorporation (50). The cell wall anchoring of pilus 
type 2a is mediated by the housekeeping SrtA through the use of the minor 
ancillary pilin as anchor protein as clearly demonstrated both by genetic (59) and 
biochemical studies (92).   
The available crystal structures of class A and C sortases from different Gram-
positive pathogens revealed similar overall folding. They share a common 
catalytic domain, based on a β-barrel core and a highly conserved catalytic triad 
made of histidine, cysteine, and arginine residues (91,93-98). Recently, a wide 
characterization of pilus-associated sortases from Streptococcus pneumoniae pilus 
1 (SrtC-1, SrtC-2, and SrtC-3) was performed, and the X-ray structures of all 3 
SrtC enzymes have been solved (94) (99). Also in this case the overall fold of the 
three enzymes is very similar to other known sortases, with a β-barrel core 
composed of eight anti-parallel β-strands linked by multiple helices. The 
conserved catalytic triad within the substrate binding region is encapsulated by the 
so-called lid that is an N-terminal flexible loop, which maintains the active site in 
a closed and inactive conformation in the absence of substrate. This loop anchors 
the active site through multiple interactions with the key catalytic residues (93,94).  
While the catalytic triad of Cys, His, and Arg side chains within the active site 
cleft is absolutely conserved among different classes of sortases (100) (101), 
including SrtA from Staphylococcus aureus, the region corresponding to the lid is 
found only in pilus-related C sortases of Gram-positive bacteria  (93) (102). 
The crystal structures of several other pilin-related class C sortases, including 
AcSrtC-1 from Actinomyces oris (97), SrtC1 from S. suis (98) and GBS 
(91,96,103), have been reported. These structures all reveal a core 8-stranded β-
barrel, with the catalytic triad (His, Cys, Arg) situated in the active site at the end 
of a groove along one side of the β-barrel. S. suis SrtC1 structure was determined 
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with the active-site in the ‘open’ conformation, while the other structures showed 
the active site occluded by the lid.  
The lid in SrtC1 from GBS PI-2a (SrtC1-2a) and Actinomyces oris SrtC2 has been 
demonstrated to be dispensable for sortase activity in vivo (91,104) suggesting a 
regulatory role for the enzyme activity.  
 
1.4.2 Structural and functional characterization of sortases C of GBS PI-1 and 2a 
 
The crystal structures of GBS C sortase from PI-2a (SrtC1-2a) and PI-1 (SrtC1-1 
and SrtC2-1) have been determined (Fig.10 and 11).  
The ectodomain of sortase SrtC1 of PI-2a was crystallized and the structure was 
solved by molecular replacement (91). 
The overall fold of SrtC1-2a is highly similar to the structure of previously 
studied pilus-associated sortases. A β-barrel made of 9 antiparallel β-strands 
forms the core of the enzyme; a so-called roof made of 3 α-helices is positioned 
above the β-barrel and a loop (known as the “mobile lid”) covers the active site 
(Fig. 10A), placed on one inner side of the β-barrel core and made of the catalytic 
triad His157-Cys219-Arg228. The lid of SrtC1-2a harbors 3 residues, Asp84, 
Pro85, and Tyr86, which make interactions with residues of the active site and 
surroundings. The aromatic benzene ring of Tyr86 is close enough to the catalytic 
Cys219 side chain to make an aromatic-sulfur interaction (91). As shown 
previously, this sulfur-aromatic interaction is conserved in other sortases 
suggesting a general mechanism of anchoring the lid within the active site (105) 
(Fig. 10B). This sulfur-aromatic interaction has been hypothesized to strengthen 
the anchoring of the lid within the active site (94). This network of interactions 
between catalytic residues and those located on the lid (Asp84 and Try86) is 
postulated to regulate the movement of the lid and therefore the access of LPXTG 
substrates to the active site (91,99). 
Through site-directed mutagenesis and in vivo complementation studies, it has 
been demonstrated that each residue in the conserved catalytic triad of SrtC1-2a 
(Fig. 10) is essential for pilus polymerization; these data confirm the relationship 
between GBS C sortases and other members of sortase family.  
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Figure 10. Overall folding of SrtC1-PI-2a and active site organization. A) Overall 
folding and B factors of SrtC1-PI-2a. SrtC1-PI-2a is represented as a cartoon, colored 
according to B-factor distribution, from low (blue) to high (red). Residues forming 
the mobile lid and the active site are shown as balls and sticks and are labeled. N and 
C termini are labeled. Carbon, oxygen, an nitrogen atoms are depicted in yellow, red, 
and blue, respectively. Position of residues 92–93 of the mobile lid, missing from the 
model because of poor electron density, is indicated by black dashes. Red arrows 
indicate the gap in the C-terminal region, fragment of residues 240–249. B) Active 
site of SrtC1-PI-2a. Residues forming the mobile lid (Asp84, Tyr86) and the active 
site (His157, Cys219, Arg228) are shown as balls and sticks, with carbon, oxygen, 
and nitrogen atoms in yellow, red, and blue, respectively. Conserved surrounding and 
interacting residues (Thr155, Ala156, Asn225) are shown as balls and sticks, with 
carbon, oxygen, and nitrogen atoms in green, red, and blue, respectively. Conserved 
hydrophobic residues are shown as magenta sticks and labeled in magenta. Distances 
between atoms are labeled and shown as red dashes. Water molecules are shown as 
red spheres. Background cartoon representation of SrtC1-PI-2a is colored according 
to B factors as in panel A (91). 
 
 
Structural and biochemical data indicated that the lid maintains the enzyme in an 
inactive and closed conformation and that, for the enzyme activation, the lid needs 
to move. Accordingly, the deletion of the lid region does not abrogate pilus 
protein polymerization because its role is not catalytic; rather, it is a catalytic 
cleft-blocking loop, and only its movement can activate the enzyme in vivo (91). 
Based on these analyses, the SrtC enzymes can be considered as having two 
functional domains: one involved in enzyme regulation and probably specificity; 
and an enzymatic region, the β-barrel core that contains the catalytic triad (95). 
Moreover, the predicted C- and N-terminal TM domains of GBS SrtC1-2a are 
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absolutely required for sortase biological function (91). The importance of TM 
domains for the enzyme activity has been recently reported by  Ton-That and co-
workers (106) who showed that the predicted C-terminal TM domain of pilus-
associated sortase SrtA is essential for efficient pilus polymerization in C. 
diphtheriae.  
Open main questions are to understand how this movement can be regulated by 
the interaction with the pilus proteins and to identify which are the residues 
involved in stabilizing the active open lid conformation of the enzyme.  
.  
 
 
Figure 11. Overall fold of GBS PI-1 SrtC1 and SrtC2 and active site organization. 
(A) Overall fold of SrtC2 and SrtC1. Residues linking the mobile lid to the second helix 
and to the first beta-strand are missing in the final structures because of poor electron 
density, and are shown here as dashed lines. (B) Active sites of SrtC2 and SrtC1. 
Residues forming the mobile lid (Asp84-Phe86 in SrtC2 and Asp90-Tyr92 in SrtC1) and 
the active site (H156, C218, R227 in SrtC2 and H163, C225, R234 in SrtC1) are shown 
as sticks where sulfur, oxygen, and nitrogen atoms, are depicted as yellow, red, and blue, 
respectively. Water molecules are shown as red spheres. (C) The DPX motif is proximal 
to the catalytic triad of SrtC2, which is surrounded by conserved hydrophobic residues 
shown as sticks, where carbon, oxygen, and nitrogen atoms, are depicted as salmon, red, 
and blue, respectively (95).  
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The crystal structures of GBS PI-1 SrtC2 and SrtC1 were also determined (Fig.11). 
In both structures, the catalytic residues are not accessible to pilin substrates, 
suggesting that the enzymes cannot bind substrates in this conformation.  
Also, these sortase C enzymes contain an additional N-terminal extension of 
approximately 50 residues, composed of one or two α-helices and a lid that blocks 
the access of substrates to the active site, further supporting the already proposed 
regulatory role played by the lid in restricting the access of the pilin substrates to 
the catalytic cleft (91,93,94). 
Both class A and class C sortases cleave LPXTG-like motifs, but only sortase C 
can polymerize the pilus proteins to form high molecular weight structures.  
In vitro and in vivo complementation studies revealed that both GBS PI-1 sortases 
C cleaved all the LPXTG-like peptides tested and exhibited a functional 
promiscuity for pilin subunit incorporation into pili, although each enzyme 
predominantly incorporates into pili one of the two ancillary subunits.  
Multiple sequence alignment of all GBS sortase C enzymes and structural 
homology modeling, showed that, in contrast with the highly similar SrtC 
enzymes of PI-1 and PI-2a, the pilus-associated sortases of PI-2b are shorter. 
In addition, even if the catalytic triad is conserved, SrtC1 from pilus 2b does not 
contain the conserved motif DPY(F/W) in the lid, and SrtC2 completely lacks this 
region and the C-terminal TM domain.  
PI-2b in GBS has a similar genetic organization to group A Streptococcus (GAS) 
FCT-3 pilus, and like GAS, it contains the LepA gene required in GAS for pilus 
polymerization (107).  
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1.5 Aim of the thesis 
 
Assembly and anchoring mechanisms of Gram-positive bacteria pili, including 
GBS pilus 1 and 2a types have already been characterized.  
In these assembly mechanisms pilin subunits are covalently linked by a 
transpeptidation mechanism by class C sortases and subsequently polymerized pili 
are anchored to the cell wall peptidoglycan by the housekeeping sortase A through 
the minor ancillary protein. The resulting protruding pili are then involved in the 
interaction with the host, mediating the bacterial initial attachment. 
The aim of this thesis work is to investigate the mechanism of GBS pilus 2b 
biogenesis unknown until now and also to elucidate its role during host interaction. 
By using a multidisciplinary approach including structural, biochemical and 
genetic studies, such as site-directed mutagenesis and complementation of KO 
GBS strains lacking the genes for each sortase (SrtC1 and SrtC2) we unraveled 
the specific role of the two sortases and identified the key residues/motifs 
essential for pilus assembly and sortases activity. 
We also elucidated pilus 2b importance during host interaction using both in vitro 
cell models and in vivo mouse meningitis model. 
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Chapter 2. Results 
 
2.1 Pilus 2b assembly  
 
2.1.1 PI-2b backbone protein characterization  
 
The backbone protein of GBS Pilus Island 2b (BP-2b) is 502 residues long and 
carries a C-terminal cell wall sorting signal (CWSS) with the typical sortase 
recognition site LPSTGG. The protein shows low sequence identity ranging from 
12 to 16% with other known backbone pilin subunits from either GBS or other 
Gram-Positive bacteria.   
To confirm the essential role of this protein during pilus 2b assembly we 
generated a mutant strain lacking the gene for the pilus 2b backbone protein 
(ΔBP-2b).  The presence of covalently-linked pili on the GBS surface was 
detected by SDS-PAGE immunoblot analysis of cell-wall preparations through 
the identification of a ladder of high-molecular-weight (HMW) bands. Western 
blotting analysis, performed with total protein prepared from the KO ΔBP-2b 
strain confirmed the key role of BP-2b in pilus 2b assembly, since the typical 
HMW laddering could not be observed as in the wild type strain. 
Complementation of ΔBP-2b with a plasmid expressing the wild type gene 
(pAM_BP-2b) restored the pili expression. 
To identify the specific residues and motives required for pilus 2b protein 
polymerization we used site-directed mutagenesis and complementation studies in 
GBS KO strains. To confirm the key role of the sortase-recognition LPSTGG 
motif of the BP-2b protein in pilus assembly, this region was entirely deleted in 
the complementation plasmid pAM_BP-2b by site-directed mutagenesis. The new 
plasmid pAM-BP-2bΔLPSTG expressing the C-terminally truncated backbone 
subunit was used to complement the GBS mutant strain (ΔBP-2b). Western 
blotting analysis, performed with total protein extracts from the complemented 
strain (ΔBP-2b/pAM_BPΔLPXTG) and probed with a BP-2b specific antiserum, 
confirmed the expression of the protein only in the monomeric form, 
demonstrating that its polymerization into HMW structures was completely 
abolished (Fig. 12).   
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The BP-2b primary sequence does not contain a “canonical” pilin motif, and four 
different lysine residues were identified in the N-terminal domain as putative pilin 
motif candidates involved in mediating the cross-linking between two monomeric 
subunits. To assess the role of each residue in pilus polymerization, each lysine 
was replaced individually by an alanine. By site-directed mutagenesis we 
generated four new complementation plasmids (pAM_BP-2bK77A, pAM_BP-
2bK82A, pAM_BP-2bK118A, pAM_BP-2bK175A) and used them to transform the KO-
strain ΔBP-2b. The complemented strains expressing mutated forms of BP-2b 
were analyzed for their ability to assemble HMW structures by immunoblotting 
analysis. We observed that the mutation of lysine 77, 82 and 118 into alanine did 
not affect pilus protein polymerization, while mutation of lysine 175 (K175A) led 
to the abrogation of pilus polymerization (Fig. 12).  
In the BP-2b sequence, a canonical “LXET” E-box motif could not be identified; 
however, BP-2b crystal structure (155) showed that Glu423 (which is part of the 
motif LVEK) is favourably positioned towards the isopeptide bond between 
Lys358 and Asn462, suggesting a possible role as for other E-box motives. To 
functionally characterize the role of this residue in pilus 2b polymerization, we 
constructed the plasmid pAM_BP-2bE423A to complement the KO ΔBP-2b. The 
expression of the backbone protein carrying the mutation E423A in the 
complemented strain abolished protein polymerization (Fig. 12), demonstrating 
the key role of residue E423 in pilus 2b assembly, although present in a non-
canonical E-box motif.  
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Figure 12. Lys 175, Glu 423 and the sorting motif LPSTG are involved in BP-2b 
polymerization in GBS. Immunoblot analysis of total protein extracts from GBS mutant 
strain lacking the pilus 2b backbone protein gene (ΔBP-2b) complemented with plasmids 
expressing the wild-type BP-2b protein (WT) or BP-2b mutants carrying a deletion of the 
C-terminal sorting signal (BP-2bΔLPXTG),  alanine substitutions of the putative pilin motif 
lysine (BP-2bK175A, BP-2bK118A, BP-2bK82A ,BP-2bK77A) or of the E-box E423 residue (BP-
2bE423A). Nitrocellulose membrane was probed with a mouse antiserum raised against the 
recombinant BP-2b protein (α-BP–2b). 
 
 
 
 
 
 
 
36 
 
2.1.2 Class C sortases in GBS Pilus Island 2b 
 
The genomic locus corresponding to GBS Pilus Island 2b (PI-2b) presents an 
overall organization similar to the other known pilus islands, carrying three genes 
coding for the structural subunits and two genes (srtC1 and srtC2) expressing for 
class C sortase enzymes (Fig. 13).  
 
 
 
Figure 13. Schematic representation of GBS pilus island 2b. The genomic island is 
composed of three structural proteins that are the backbone protein (BP) that constitutes 
the scaffold of pilus structure, and ancillary proteins 1 and 2 located at the tip and the 
base respectively. These genes coding for structural subunits are represented by red 
arrows. In the genomic island are also present two genes coding for two class C sortases 
(in green) and also a signal peptidase Lep gene (yellow arrow), that is not present in the 
other GBS PIs. 
 
 
As previously reported (91), by multiple sequence alignment with other class C 
sortases performed using ClustalW, SrtC1 and SrtC2 of PI-2b revealed a very low 
percentage of amino acid identity (Fig. 14). 
SrtC1-2b and SrtC2-2b proteins consist of 291 and 199 residues, respectively. 
Prediction of transmembrane (TM) helices using their primary sequences revealed 
that SrtC1 carries two TM regions at the N-terminal (residues 7-29) and at the C-
terminal (region 246-268), while the SrtC2 protein lack the predicted C-terminal 
trans-membrane (TM) helix, showing only a N-terminal TM (residues 4-27). 
 
 
37 
 
 
 
 
Figure 14. PI-2b Sortases C do not contain the canonical lid motif. Sequence 
alignment of all GBS class C sortases. Sequences corresponding to the lid region of 
sortases are highlighted in a blue box with a green star. Red stars are indicating the 
catalytic triad residues. PI-2b SrtC2 is also lacking the C-terminal transmembrane domain.  
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2.1.3 Generation of GBS mutant strains lacking sortase genes 
 
To functionally characterize the role of the two sortases C in pilus 2b assembly, 
we generated two knock-out (KO) mutant strains (ΔsrtC1 and ΔsrtC2) carrying 
in-frame deletions for each sortase gene using Splicing by Overlap Extension 
(SOE) PCR in a GBS strain (ABC020017623) containing only the genomic pilus 
island 2b (Suppl. Table 1). Sequence analysis of PI-2b in this strain confirmed 100% 
gene conservation with respect to the entire locus sequences of GBS strain COH1 
whose complete genome is available in the public databases. 
ΔsrtC1 KO strain resulted in the srtC1 gene deletion of the region corresponding 
to amino acid residues 11 to 259, while ΔsrtC2 mutant resulted in the deletion of 
SrtC2 amino acid residues 14 to 190. Confirmation of these in-frame deletions 
were obtained by sequence analysis.  
 
 
 
2.1.4 SrtC1 is the only pilus 2b-associated sortase involved in pilin subunit 
polymerization 
 
To assess the role of each sortase in pilus protein polymerization, total proteins 
were extracted from each mutant strain and analyzed by immunoblot analysis with 
antisera specific for each structural subunit (the backbone and the ancillary 
subunits). As expected, total proteins from the wild type strain revealed the 
canonical HMW laddering indicative of pilus-like structures, while unexpectedly, 
only the deletion of sortase C1 affected pilin proteins polymerization, completely 
abrogating it, whereas ΔsrtC2 KO strain was able to express and assemble HMW 
pilus-like structures, as well as the wild type strain (Fig. 15A-B-C).  
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Figure 15. Only SrtC1-2 is essential to polymerize the pilin proteins into high 
molecular weight (HMW) structures. Immunoblotting analysis of total protein extracts 
from ABC020017623 wt and mutant strains lacking srtC1-2b and srtC2-2b genes 
(ΔSrtC1 and ΔSrtC2) or mutants complemented by plasmids expressing SrtC1-2b or 
SrtC2-2b (ΔsrtC1+pAM_srtC1 and ΔsrtC2+pAM_srtC2). Nitrocellulose membranes 
were probed with antisera raised against the backbone protein of pilus 2b (α-BP-2b), the 
major ancillary AP1 protein (α-AP1–2b) and the minor ancillary AP2 protein (α-AP2–2b). 
The equal amount loaded in each well was verified by probing the same gel with a control 
antiserum that recognizes the constitutive protein PcsB of 47 kDa (in the lower panels 
indicated by a black arrow).  
 
Interestingly, the deletion of srtC2 gene did not cause any effect on the backbone 
protein polymerization (Fig. 15A) and on the incorporation of the major ancillary 
protein (AP1) into pili (Fig. 15B), while the incorporation into pili of the minor 
ancillary protein (AP2) resulted significantly reduced (almost totally abrogated) 
(Fig. 15C). Complementation of the srtC1 gene restored proteins polymerization 
to levels comparable to those of the wild type strain (Fig. 15A-B-C) as well as the 
complementation of the srtC2 gene into the ΔsrtC2 mutant restored the AP2 
incorporation into the pili as well as the wild type strain (Fig. 15C). These data 
clearly indicate that only the sortase C1 is involved in pilus 2b formation, while 
the sortase C2 appears to be dispensable for the backbone protein polymerization 
and it could play a role in the AP2 incorporation into pili. 
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2.1.5 The lack of SrtC2 induces release of polymerized pili in the culture 
supernatant 
 
Since it is known that the minor ancillary subunit is involved in the cell-wall 
anchoring of other pili, including GBS pilus type 2a (59,92), we hypotized that 
sortase C2, not affecting the process of pilus protein polymerization, could be 
involved in pilus anchoring to the cell-wall through the use of the AP2 protein. To 
investigate this hypothesis, we analyzed the presence of pili released into the 
culture supernatant of the mutant strains deleted of srtC2 and ap2 genes. Thus, we 
also generated the knock-out (KO) mutant strain (Δap2) carrying in-frame 
deletion for ap2 gene (Suppl. Table 1). Thus, both mutants were cultured in 
chemically defined medium so that levels of pilus found in the extracellular and 
cell-associated fractions could be directly compared.  
Total proteins from the cell-wall and supernatant fractions were extracted and 
equal amounts were analyzed by immunoblot with an antiserum specific for the 
backbone protein. As shown in figure 16, in the wild type strain almost all the 
polymerized pili were detectable only in the cell-associated fraction. Whereas no 
pilus proteins were detected in the extracellular fraction of the wild-type strain, by 
contrast, significant amounts of pili were released in the culture supernatants of 
srtC2 and ap2 mutant strains, which revealed a highly comparable phenotype 
(Fig. 16). Protein profiles comparable to those of the wild type were restored upon 
complementation of srtC2 and ap2 mutants with vectors expressing the 
corresponding wild type genes (Fig. 16). These data indicate, therefore, that in the 
absence of SrtC2 or AP2 protein, polymerized pili structures were produced at 
levels comparable to those of the wild type strain, but then they were lost from the 
bacterial cell surface and released into the culture supernatant, suggesting that 
SrtC2 could be involved in pilus anchoring process by using the minor ancillary 
protein 2 (AP2) as anchor protein. 
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Figure 16. Pili are mostly released in the culture media of the mutant strains ΔsrtC2 
and Δap2. Proteins were collected from RPM1 culture supernatants (right panel) or 
extracted from cell pellets (left panel) of GBS wild-type strain (WT), or mutant strains 
deleted of srtC1, srtC2 or ap2 genes (ΔsrtC1, ΔsrtC2 and Δap2, respectively) and mutant 
strains complemented with the plasmids expressing  SrtC1, SrtC2 or AP2-2b proteins 
(ΔsrtC1+pAM_srtC1, ΔsrtC2+pAM_srtC2 and Δap2+pAM_ap2, respectively). Protein 
fractions were analyzed by immunoblot stained with antibody specific for the backbone 
protein BP-2b (α-BP-2b, in the upper panels), and as a quantitative control of equal 
amount of proteins loaded in each well with the serum against the constitutive protein 
PcsB (in the lower panels). 
 
 
 
2.1.6 Biochemical characterization of SrtC2-2b  
 
To further investigate the role and the specificity of sortase C2 in pilus 2b 
assembly we performed a biochemical characterization of the enzyme. We first 
cloned and expressed in E. coli the catalytic domain of SrtC2 enzyme (residues 
32-199) as an N-terminal His-tagged recombinant protein lacking the N-terminal 
hydrophobic region and the leader sequence. The soluble protein (rSrtC2) was 
then purified by immobilized metal affinity chromatography (IMAC) followed by 
size-exclusion chromatography (SEC). The purified enzyme (SrtC232–199) 
showed >90% purity by SDS-PAGE. Gel filtration revealed that in the analyzed 
peak the protein was mono-disperse with an apparent molecular weight (MW) of 
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25 kDa, consistent with the theoretical MW of 23.9 kDa of the monomeric protein 
(Fig. 17).  
 
 
Figure 17. SrtC2 purification. Recombinant SrtC2 was cloned expressed and purified. 
SDS-PAGE of the purified enzyme after last purification step by size-exclusion 
chromatography (SEC).  The corresponding SEC graph is also reported, where the blue 
peak corresponds to the purified protein fraction. 
 
 
2.1.7 Recombinant SrtC2 specifically recognizes and cleaves the sorting motif of 
the AP2-2b protein  
 
As a precondition to evaluate the enzymatic activity of the produced sortase, we 
verified the folding of the enzyme by Nuclear Magnetic Resonance (NMR) 
spectroscopy using a purified 15N-labeled recombinant SrtC2. The 1H-15N-HSQC 
NMR spectrum provides amino acid-specific information, showing signals from 
all HN groups of the protein, including backbone amide groups as well as a 
number of side chains. Therefore, it is a valuable tool to evaluate protein folding, 
as the secondary and tertiary structures determine unique chemical environments 
of amide groups, which are reflected by significant signal dispersion in both the 
nitrogen and proton dimensions. An unfolded protein displays poor signal 
dispersion because all amide atoms are in similar chemical environments (for 
example exposed to the solvent). The 1H-15N-HSQC spectrum of SrtC2-2b 
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showed a significant dispersion of peaks in both the proton and nitrogen 
frequency dimensions  (spanning ~ 5 ppm and ~ 30 ppm respectively) indicating 
that the enzyme was correctly folded (Fig. 18).  
  
 
 
 
Figure 18. Recombinant SrtC2 is correctly folded. Recombinant SrtC2 was cloned 
expressed and purified, and the correct folding was checked by NMR to verify the correct 
folding of the protein. NMR spectroscopy of the purified recombinant 15N-labelled-
SrtC2-2b. The 1H-15N-HSQC spectrum of the protein was recorded in 50 mM phosphate 
buffer, pH 6.5 and acquired at 25°C. The signals of the residues are consistent with a 
folded protein. 
 
To evaluate its in vitro enzymatic activity we performed a Fluorescence 
Resonance Energy Transfer (FRET) based assay using synthetic fluorogenic 
peptides mimicking the LPXTG-like sorting motives of pilin proteins. FRET 
analysis is a commonly used method to follow cleavage reaction of specific 
substrates by specific enzymes, such as sortases. When the peptide is cleaved by 
the sortase, the EDANS fluorophore group is separated from the DABCYL 
quencher group, resulting in an enhanced fluorescence signal. We first tested 
synthetic peptides carrying the LPXTG-like motifs of the three pilus 2b structural 
proteins (Table 3). The LPSTGG-motif of the backbone protein (BP-2b) overlaps 
with the motif of the major ancillary protein (AP1-2b), and differs from the 
sorting signal LPFTGQ of the minor ancillary protein (AP2-2b). A significant 
increase of the fluorescence signal (normalized against the fluorescence values of 
the peptide alone) was observed only when the rSrtC2 sortase was incubated with 
the AP2-2b peptide, indicating that this enzyme specifically recognizes and 
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cleaves only this peptide (Fig. 19A). By contrast, rSrtC2 was not able to cleave 
neither the BP-2b/AP1-2b peptide nor the peptide containing the LPKTGM motif 
of the AP2 protein of pilus 2a (AP2-2a) used as control (Fig. 19A). We have 
chosen this peptide as control since we had previously demonstrated that it is the 
substrate target of the GBS housekeeping sortase A (SrtA), which is responsible 
of the cell-wall anchoring of pilus 2a through the AP2-2a subunit that is at the 
base of the pilus and acts as the pilus anchor protein (92). To confirm the cleavage 
specificity of rSrtC2 vs the AP2-2b peptide, we verified if the AP2-2b peptide was 
also recognized and cleaved by the housekeeping SrtA. Thus, we expressed in, 
and purified from E. coli the SrtA, as an N-terminal His-tagged recombinant 
protein, and performed an in vitro FRET assay by incubating 5µM of rSrtA with 
64 µM of the fluorescent AP2-2b peptide or the AP2-2a peptide used as positive 
control (92). We observed that the rSrtA enzyme cleaved specifically only the 
AP2-2a peptide as expected, but was not able to cleave the AP2-2b motif, 
confirmed that the AP2 protein of pilus 2b was the specific substrate of SrtC2 (Fig. 
19B). 
 
 
 
Figure 19. SrtC2 specifically cleaves AP2-2b fluorescent peptide. In vitro enzymatic 
activity assessed by FRET analysis of the recombinant wild-type SrtC2 (A) or SrtA (B) 
proteins using fluorogenic peptides (64 μM) carrying the LPxTG-like motif of the minor 
ancillary protein 2 from pilus 2b (AP2-2b), of minor ancillary protein 2 from pilus 2a 
(AP2-2a) and the sorting motif of pilus 2b backbone protein overlapping with that of the 
major ancillary (AP1/BP-2b). Progress curves of the cleavage reactions of the fluorescent 
peptides catalyzed by recombinant SrtC2 wild-type (SrtC2WT) or SrtA wild-type (SrtAWT) 
show that SrtC2 is specific only for AP2-2b  that instead can not be cleaved by 
housekeeping SrtA. Each assay was done in triplicate and the graphs report the mean 
values. 
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To further confirm these data we performed an in vitro cleavage assay by 
incubating the rSrtC2 or rSrtA enzyme with a recombinant C-terminal His-tagged 
protein (rAP2-2b) produced in E. coli. 50µM of rSrtC2 or rSrtA was incubated at 
37°C over-night with 25µM of rAP2-2b. Reaction mixtures were then purified by 
IMAC and the fractions were analyzed by Western Blot using a mouse antiserum 
α-AP2-2b. The IMAC purification allowed eluting only His-tagged proteins or 
peptides and releasing in the flow through fraction any protein/peptide lacking the 
His-tag. Accordingly, if the C-terminal His-tagged AP2-2b protein is not cleaved 
by a sortase at its C-terminal sorting signal, AP2-2b will be collected only in the 
elute fraction. By contrast, the cleavage of its sorting signal will be proved by the 
presence of the cleaved AP2-2b protein in the flow through fraction. Antibodies 
specific for the AP2-2b protein revealed a band at a lower MW than the size of the 
full length AP2-2b in the flow through fraction only when the rAP2-2b protein 
was incubated with rSrtC2 (Fig. 20), meaning that the protein was cleaved only by 
SrtC2 with the consequent loss of the His-tagged sorting signal. Accordingly, the 
protein eluted completely full-length when incubated with the rSrtA (Fig. 20). 
 
 
Figure 20. AP2-2b is cleaved only by SrtC2 and not by SrtA. In vitro cleavage assay 
of the recombinant C-terminal His-tagged AP2-2b protein incubated either with the 
recombinant SrtC2 or SrtA. Cleavage reactions were then purified by IMAC and the 
single fractions were analyzed by Western blot using a mouse serum anti AP2-2b.  
 
These data, taken together with the above described experiments strongly suggest 
that pilus 2b is anchored to the cell wall through the minor ancillary protein AP2, 
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which is the specific target of the pilus-associated SrtC2. Moreover, FRET 
experiments confirmed genetic data indicating that SrtC2 is not involved in 
backbone protein polymerization, since it is not able to cleave its sorting motif. 
 
2.1.8 C115 and C192 are not essential for the SrtC2 activity in vivo  
 
Sequence analysis of SrtC2-2b by multiple alignment with other GBS sortase 
reveals the presence of two more cysteines (C115 and C192) in addition to the 
conserved canonical triad represented by H117, C180 and R187 (Fig. 14). 
Moreover, also SrtC2-2b (as SrtC1-2b) does not contain the canonical DPY\W\F 
lid motif. To investigate the possible involvement of those cysteines in the 
catalytic activity of SrtC2-2b, we generated complementation vectors expressing 
three mutated forms of SrtC2 (SrtC2C115A, SrtC2C180A and SrtC2C192A). Each 
cysteine residue was individually replaced by an alanine into the complementation 
vector pAM_SrtC2 by the PIPE method and site-directed mutagenesis using 
synthetic oligonucleotide primers. The new vectors carrying the specific 
mutations were then used in restoring the activity of the enzyme by transforming 
the KO mutant strain srtC2. After complementation, the effect of each mutation 
was analyzed by Western blot analysis, checking the release of polymerized pilus 
structures in the culture media supernatants from complemented strains. As 
expected, no high-molecular-weight polymerized pilus structures were found in 
the media supernatants of the complemented strains with the gene expressing the 
wild type (SrtC2wt) and the mutated enzymes (SrtC2C115A and SrtC2C192A), 
meaning that these sortase forms restored pilus 2b anchoring to the cell wall 
(Figure 21). By contrast, by complementing the KO SrtC2 strain with the 
plasmid expressing the sortase carrying the C180A substitution released 
polymerized pili could still be detected in the culture medium, confirming that 
Cys180 is the catalytic residue essential for sortase C2 activity (Figure 21). 
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Figure 21. Cysteine 180 is responsible for catalytic activity of SrtC2-2b. Western Blot 
analysis of total proteins collected from culture media supernatants of GBS wild type 
strain (WT), GBS knock out strain deleted of srtC2 gene (srtC2) and srtC2 strain 
complemented with the plasmids pAM_SrtC2WT (ΔsrtC2+srtC2wt), pAM_SrtC2C115A 
(ΔsrtC2+srtC2C115A), pAM_SrtC2C180A (ΔsrtC2+srtC2C180A), pAM_SrtC2C192A 
(ΔsrtC2+srtC2C192A), expressing SrtC2 cysteine mutant enzymes. Nitrocellulose 
membrane was probed with a mouse antiserum raised against the backbone protein (α-
BP-2b). The equal quantity loaded in each well was verified by immunoblotting the same 
gel with a control antiserum specific for the constitutive PcsB protein of 47 kDa (in the 
lower panel). 
 
2.1.9 C115, C180 and C192 are not essential for the SrtC2 structural stability 
 
Antibodies specific for SrtC1 or SrtC2 enzymes revealed that all the 
complemented strains expressed similar levels of the different forms of sortases, 
indicating that none of the introduced mutations had seriously affected the 
expression or the stability of the proteins (data not shown).  
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Moreover, to verify whether the Cys115 and Cys192 residues affected the general 
fold of SrtC2-2b, the mutant enzymes rSrtC2C115A, and rSrtC2C192A were produced 
as recombinant 15N-labeled proteins and analyzed by NMR spectroscopy.  
The analysis of the HSQC spectra of the SrtC2 mutants showed that the signal 
dispersion is comparable to the WT meaning that each single mutation did not 
alter the overall structure of the proteins. Moreover, the spectra of the WT and of 
the mutants are highly superimposable with only few peaks showing chemical 
shift changes. Since peak position is very sensitive to chemical environment, this 
scenario is compatible with local modifications introduced around the mutation 
sites. Overall, it can be concluded that the mutated residues did not affect 
structural stability of the SrtC2 enzyme, as the native fold was preserved (Figure 
22A).  
 
2.1.10 Disulfide bonds formation between catalytic C180 and C192 suppress 
SrtC2 activity in vitro  
 
To better investigate the contribution of the cysteines in SrtC2-2b activity the in 
vitro enzymatic activity of the SrtC2 mutants (rSrtC2C115A, rSrtC2C180A and 
rSrtC2C192A) compared with the rSrtC2wt was assessed by FRET assay and the 
presence of free thiols assessed by AMS assay 
Recombinant sortases were generated by site-specific mutagenesis using as 
template the previously generated pET vector carrying the wild type SrtC2 gene. 
Thus, the mutated SrtC2 were produced in E. coli as His-tagged recombinant 
proteins. The proteins were incubated at a concentration of 25 µM each with 
different concentrations of the fluorescent AP2-2b peptide and their activity was 
tested. In agreement with the above described data, the activity of SrtC2C180A 
enzyme was completely abolished, further confirming the catalytic role of this 
residue. Interestingly, the mutant SrtC2C192A showed an enhanced cleavage 
activity compared with the wild type enzyme, whereas the mutant SrtC2C115A 
revealed a highly reduced activity (Figure 22B).  
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Figure 22. SrtC2 mutants characterization. SrtC2 differs from the other class C 
sortases because it has three cysteines needed for its activity and regulation. Recombinant 
SrtC2 with cysteines mutated one at the time, were cloned expressed and purified, and 
their correct folding was analyzed by NMR. A) Superimposition of NMR 1H-15N HSQC 
spectra of SrtC2 wild-type and its mutants. Cyan, SrtC2 wild-type; red, SrtC2C115A or 
SrtC2C192A. All samples are in 50 mM phosphate buffer, pH 6.5. B) FRET assay with 
rSrtC2 and its cysteine mutants at a concentration of 5 μM with 128 μM of the fluorescent 
peptide with the AP2-2b LPXTG motif.  The assay was performed at 37°C in 50 mM 
Tris-HCl (pH 8), 300 mM NaCl, 1 mM DTT and was performed at least in triplicate. The 
graph shows that SrtC2C192A mutant is more active than the wild type sortase. Mutation of 
the catalyitic cysteine completely abrogates SrtC2 activity as expected, but also mutation 
of cysteine 115 leads to a decrease of fluorescence measured. 
 
Interestingly, with the only exception of the C180 mutant, the activity of the other 
three samples correlated with the fluorescence values in the AMS assay (Fig.23). 
AMS specifically binds to free thiols and the sample fluorescence measured after 
the excess of AMS is removed is directly proportional to the number of free 
cysteines (108). In fact, the SrtC2C192A mutant that showed maximum cleavage 
activity revealed also the higher AMS fluorescence. In fact, the rSrtC2C192A that 
was characterized by maximum activity revealed also the higher AMS 
fluorescence. Pre-treatment of this protein with DTT did not modify the 
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fluorescence value, meaning that the number of its free cysteines does not change 
in the reduced form; the catalytic Cys180 remains free and thus active. On the 
contrary, the SrtC2C115A mutant characterized by low FRET activity showed in 
absence of DTT a low AMS fluorescence that increased when the sample was pre-
treated with DTT. This observation indicates that the poor (almost no) enzymatic 
activity in vitro of SrtC2C115A is due to a disulfide bond formation between 
Cys192 and the catalytic Cys180, which thus results locked in its activity. As 
SrtC2wt showed an intermediate enzymatic activity and intermediate AMS 
fluorescence value, likely a balance between Cys192-Cys180 and Cys192-Cys115 
disulfide bonds could exist. AMS results suggest that in SrtC2wt the Cys192 could 
be engaged in a disulfide bond with either Cys115 or Cys180, since both the 
mutants SrtC2C115A and SrtC2C180A after incubation with AMS resulted in the same 
fluorescence values. On the contrary, Cys115 and Cys180 are not able to directly 
interact to each other in a disulfide bond, and indeed the mutant SrtC2C192A seems 
to contain free cysteines in all tested conditions (Fig. 23). 
 
 
Figure 23. SrtC2 free cysteines quantification by AMS assay. 25 μM recombinant 
SrtC2 wt or cysteine mutated in both reduced and oxidized forms were incubated at 37°C 
for 30’ with 250 μM AMS and SDS 1%. AMS binds to free cysteine thiols and the 
measurement of its fluorescence allow free cysteines quantification. SrtC2C192A is the only 
protein where the number of free cysteines does not change if reduced or not, meaning 
that the other two cysteines never interact between them, but only with cysteine 192 
alternatively. 
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2.1.11 Overall folding of SrtC1-2b  
 
To further elucidate the different roles of SrtC1-2b and SrtC2-2b in pilus 2b 
biogenesis we performed X-ray crystallography structural studies and solved the 
crystal structure of the sortase C1 (SrtC1-2b).  
The ectodomains of SrtC1-2b and SrtC2-2b enzymes were produced in E. coli as 
soluble recombinant proteins containing via a TEV-cleavable N-terminal 6-His-
tag and purified using standard chromatographic techniques as described in the 
Materials and Methods chapter and used in crystallization trials.  
While all attempts to obtain crystals of SrtC2-2b enzyme failed, the crystal 
structure of SrtC1-2b was solved at 1.95 Å by molecular replacement in molrep 
(109), starting with a template made of coordinates of GBS SrtC1-1 (PDB ID 
4g1j) (51.9% sequence identity) (Table 4, Fig. 24).  
 
 
 
Figure 24. SrtC1-2b crystal structure. SrtC1-2b is depicted as cartoon colored 
according to B-factor distribution, using a gradient from blue (22 Å2) to red (120 Å2). 
Residues forming the catalytic triad and the Trp residue of the lid (W78) are shown with 
sticks and labelled. 
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Like for other sortase family members, the overall fold of SrtC1-2b exhibits a core 
made of a β-barrel compact structure with 10 β-sheets, surrounded by an α helical 
roof composed of 4 consecutive helices (Fig. 24). The first N-term helix (residues 
39-51) runs parallel to the wall of the β-barrel core, whereas the second (residues 
53-69), the third (residues 70-75) and the fourth helices (residues 81-90) run 
almost perpendicular to the first helix and flat on the top of the β-barrel (roof). 
The loop connecting helices 3 and 4 and carrying residues 76-80 corresponds to 
the “lid” region and includes a tryptophan residue (W78). The catalytic triad is 
made of the residues His149, Cys211, and Arg220 that belong to three different 
strands of the lower part of the β-barrel (Fig. 24). 
To confirm the catalytic role of C211 in SrtC1 activity, this cysteine was replaced 
by site-directed mutagenesis with an alanine into the complementation plasmid 
pAM_srtC1. The generated new plasmid (pAM_srtC1C211A) was used to transform 
the mutant strain srtC1. Western Blot analysis performed with total protein 
extracts from the complemented strain (srtC1+pAM_srtC1C211A) and probed 
with an anti-backbone protein serum (α-BP-2b) showed that the polymerization of 
the major subunit of pilus 2b was completely abolished confirming the catalytic 
function of C211 (Fig. 25). 
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Figure 25. Cysteine 211 is responsible for catalytic activity of SrtC1-2b. Immunoblot 
of total protein extracts from GBS wild-type (WT), mutant strain lacking the sortase C1 
gene (ΔsrtC1) and ΔsrtC1 mutant strain complemented with the plasmid pAM_SrtC1WT 
(ΔsrtC1+srtC1wt) and the plasmid pAM_SrtC1C211A (ΔsrtC1+srtC1C211A) expressing the 
SrtC1 enzyme carrying the substitution of the cysteine 211 with an alanine. The equal 
quantity loaded in each well was verified by immunoblotting the same gel with a control 
antiserum that recognizes the protein PcsB of 47 kDa (in the lower panel). 
 
 
2.1.12 Structural comparisons of SrtC1-2b with other sortases 
 
A search of the Protein Data Bank (PDB) using the program DALI (110) revealed 
high structural similarities (Z-scores > 2) with more than 100 non-unique sortase 
family proteins. Among these, the highest Z-scores (>13) and lowest rmsd values 
unique entries (corresponding to class C or A sortases) were selected and analyzed 
by structural superposition onto the coordinates of SrtC1-2b (Suppl. Table 5). 
This analysis confirmed a highly conserved overall fold, but revealed how the lid 
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of SrtC1-2b assumes an apparent novel conformation. While for most structurally 
similar entries the lid is either not visible (likely because flexible and thus 
disordered), or closed to make interactions with the catalytic triad residues, in 
SrtC1-2b this assumes an “open” position. Although DALI also detected as highly 
similar two structures with an open lid conformation (PDB ID 3re9, which is the 
crystal structure of sortase C1 from S. suis, and PDB ID 3tb7 for GBS SrtC1-1 
(type I), with Z-scores of 23.6 and 22.5, respectively), both these structures have a 
lid made of a long helix that does not superpose well with the lid of SrtC1-2b. 
Coordinates of SrtC1 from S. pneumoniae (PDB 2w1j),  the only sortase structure 
with electron density for the whole N-terminal region, and of GBS SrtC1-1 (PDB 
4g1j) were used for further manual structural alignments and analyses.  These 
revealed a β-barrel core structurally well conserved and a perfect superimposition 
of the catalytic triad residues, with rmsd values of 1.6 Å and 1.5 Å, for 2w1j and 
4g1j, respectively (Fig. 26A-B). The N-terminal α helical portion, extending from 
S74 to D87, including the lid loop, revealed a significant difference. The putative 
regulatory lid tryptophan residue W78 in SrtC1-2b structure, which corresponds 
to residues W60 and Y92 in 2w1j and 4g1j, respectively (Fig. 26A-B) is displaced 
almost 15 Å away from the catalytic triad in the substrate binding active site. A 
multiple sequence alignment of SrtC1-2b and the other crystallized pilus-related 
sortases showed that only SrtC1-2b does not contain the canonical DPY\W\F lid 
motif, but just a tryptophan (W78) (Fig. 27).  
To gain a better understanding of the open lid conformation of SrtC1-2b, we 
superimposed it onto the coordinates of the “open-form” structure of S. suis 
sortase C1 (PDB id 3re9). An overall good structural agreement was obtained 
(with rmsd value of 2Å), except for the lid region, where significant differences 
could be observed (Fig. 26C). While in S. suis SrtC1 the lid is made of 28 residues 
(N79-E107) that mainly form an α-helix, the lid of SrtC1-2b is made of a total of 
14 residues (M76-Q90) and includes a loop (residues 76-80) and an α-helix (α4, 
residues 81-90). An angle of  ~70º was measured between the helical lid of S. suis 
SrtC1 and α4 of SrtC1-2b (Fig 26C), resulting in the regulatory lid Y87 residue of 
SrtC1_suis positioned farther away from the catalytic triad, as well as from W78 
of SrtC1-2b (Fig. 26C). This suggests that S. suis SrtC1 has an even more open 
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conformation than SrtC1-2b, thus supporting the notion of high flexibility of the 
lid (99). 
 
 
 
Figure 26. Open and closed lid of Sortase C structures. The structure of SrtC1-2b is 
depicted as dark gray cartoon in all panels, and the lid region colored in blue. 
Superposition of SrtC1-2b onto the structures of (A) SrtC1 of S. pneumoniae (PDB 2w1j, 
light gray cartoon), (B) GBS SrtC1-1 from pilus type 1 (PDB 4g1j, light yellow cartoon). 
(C) Zoom into the region of the catalytic triad and of the lid, showing with green sticks 
residues of SrtC1-1, with red sticks those of S.pneumoniae SrtC1. and with gray sticks 
those belonging to SrtC1-2b. The distance between Cα atoms of the aromatic lid residue 
is also shown, to highlight the displacement of the lid in SrtC1-2b. (D) Superposition of 
SrtC1-2b onto the SrtC1 from S. suis (PDB 3er9, orange cartoon). The lid regions of 2w1j, 
4g1j, and 3er9 are colored in red, green, and magenta. Superimposed residues of the 
catalytic triads of all structures, as well as aromatic residues of the lids, are shown with 
sticks and colored accordingly to the structure or region to which they belong. 
56 
 
 
Figure 27. Multiple sequence alignment of the pilus-forming sortases deposited in 
the protein data bank (PDB). Structure-based sequence alignment by using ESPript of 
GBS SrtC1-2b (PDB 4D7W), GBS pilus 1 SrtC1-1 (PDB 4G1J) and Srt2-2b-1 (PDB 
4G1H), GBS pilus 2a SrtC1-2a (PDB 3O0P), S. pneumoniae sortase C1 (PDB 2W1J), 
sortase C2 (PDB 3G69), and sortase C3 (PDB 2W1K), S. suis SrtC1 (PDB 3RE9) and A. 
oris SrtC1 (PDB 2XWG). Identical residues are shown with a red background, whereas 
similar residues are shown in red and highlighted with blue boxes. Residues located 
within the active site cleft (His, Cys and Arg) are conserved among all sortases and are 
highlighted with blue stars, whereas the lid residues DPF\Y\W are highlighted with a red 
box. 
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2.2 Pilus 2b functional characterization 
 
2.2.1 The expressions of different pilus types in the same GBS strain are 
independent 
 
To study the function of different pilus types in GBS pathogenesis  we used two 
mutant strains previously generated in COH1 strain, a well-known serotype III-
ST-17 isolate, which expresses pilus 1 and pilus 2b (50). Each mutant strain 
carried an in-frame deletion of the gene coding for the backbone protein (BP) of 
pilus 1 (BP-1) or of pilus 2b (BP-2b), respectively. Total proteins were 
extracted from each mutant strain and analyzed by immunoblot analysis using 
sera anti BP-1 or 2b. Total proteins from the wild type strain revealed the typical 
HMW laddering indicative of pilus-like structures, whereas this laddering was not 
present in the two deletion mutant strains, suggesting that protein polymerization 
was completely abrogated. Complementation of BP genes restored protein 
polymerization to levels comparable to those of the wild type strain (50), 
confirming that the presence of the backbone proteins is fundamental for pili 
polymerization.  
 
 
 
Figure 28. Schematic representation of COH PI-1 and PI-2b.  COH1 strain has two 
different pilus genomic islands. PI-1 and PI-2b and they both encode for the three 
structural pilins and for two class C sortases. In this study two different mutant strains 
were used, each deleted of a different BP protein. 
 
To analyze if the deletion of a BP in one genomic pilus island (PI) could influence 
the expression of the other one, a FACS analysis on whole bacteria was performed 
using monoclonal antibodies anti BP-1 and BP-2b. Antibodies raised against the 
BP-2a of pilus 2a and anti-polysaccharide type-III were used as negative and 
positive control, respectively. As shown in figure 29, backbone protein 
expressions from different pilus islands are independent, meaning that the 
mutation of one pilus island does not affect the protein expression of the other 
58 
 
pilus island. These results confirm that these mutants as appropriate tools for our 
analysis. 
 
 
 
Figure 29. Different backbone protein expressions are independent. FACS analysis 
on COH1 wt and BP deletion mutant strains. Antibodies against BP1 and 2b were used to 
check the single deletion of each BP in the two mutant strains generated. It was used also 
to check if this single deletion could affect the expression of the other backbone protein. 
An antibody anti-serotype III was used as positive control and one against BP2a as 
negative control. As reported in the graph the deletion of one backbone protein do not 
influence the expression of the other one.  
 
2.2.2 Pilus 2b is the one involved in COH1 adherence to host cells 
 
The analysis of pili function upon host-cell interaction started with in vitro cell-
based assays. Different cell lines were used, including human brain microvascular 
endothelial cells (hBMEC), vaginal epithelial cells (VK2/E6E7) and lung 
epithelial cells (A549). All the cell lines were incubated with bacteria at an MOI 
of 1 and all assays were done in triplicate. As shown in figure 30A, only when 
type 2b pilus is deleted, COH1 is significantly less adherent and therefore less 
invasive in hBMEC cells. The complemented strain expressing BP-2b restored 
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normal levels of adherence and invasion comparable to those of the wild type. The 
deletion of type 1 pilus did not result in any significant difference in terms of 
adherence and invasion from the wild type strain. 
 
Figure 30. Pilus 2b backbone protein deletion affects GBS interaction with the host. 
COH1 wt and BP mutant and complemented strains were tested in adherence and 
invasion assays with human brain microvascular endothelial cells (hBMEC), vaginal 
epithelial (VK2/E6E7) and lung epithelial (A549) cells. A) Only the deletion of BP-2b 
causes a significant decrease in both adherence and invasion to hBMEC while instead the 
deletion of BP-1 do not. Same results can be observed after GBS incubation with lung 
epithelial cells (18B). C) When GBS is incubated with vaginal epithelial cells both 
mutants result in a decrease in terms of adherence, but also in this case the deletion of 
BP-2b results in a dramatically decrease in adherence. All the complemented strains 
restored the wt phenotype. 
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Same results were obtained for lung epithelial cells (Fig. 30B). Cell adherence 
assay was done also with vaginal epithelial cells, and similar results were obtained 
but in this case also the ΔBP-1 mutant caused decreased adherence to the cells.  
This suggests that this pilus type could be normally involved in more specific 
interaction with this kind of cells (Fig. 30C). 
To further investigate how pili affect the adherence to host cells, we tested GBS 
binding abilities to Extracellular Matrix (ECM) components by using ECM 
proteins coated plates. As reported in figure 31, both mutants caused significant 
binding decreases to collagen, fibrinogen and laminin and fibronectin, which 
suggested that pili may contribute to GBS attachment to host cells through ECM 
binding.  Especially the ΔBP-2b mutant resulted in a decreased binding ability to 
ECM components.   
 
 
 
 
Figure 31. Pilus 2b is important for fibronectin binding. Wild-type GBS strain and 
ΔBP mutant strains were incubated with ECM components for and adherence assay.  All 
the mutant strains tested gave significant differences in comparison to the wild-type. In 
particular BP-2b looks to be important for the binding to fibronectin. In fact when pilus 
2b BP is deleted, GBS adherence significantly decrease; when instead is the only one 
present because BP-1 is deleted, GBS binding to fibronectin increase in a significant way. 
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2.2.3 Pilus 2b contributes to pathogenesis of meningitis in vivo 
 
We have shown that type 2b pilus in in vitro assays resulted in a decreased 
adherence and invasion to all the cell lines tested and ECM components. To test if 
these findings could be confirmed also in vivo, we decided to examine different 
pili contribution to the pathogenesis of GBS CNS (central nervous system) infec-
tion in vivo.  
Since ECM components and fibronectin have been demonstrated to be on brain 
endothelium (42) we thought that this binding could be an initial step for BBB 
penetration and meningitis development. We employed our mouse model of GBS 
hematogenous meningitis, as described previously (40,42,111,112). Ten mice per 
group (8-week, CD-1 male) were intravenously injected with either WT GBS or 
one of the two ΔBP mutants at a concentration of 1.5x108 CFU. They were 
monitored for survival every three hours and they were sacrificed after 48 hours. 
After collecting and homogenizing brain and lungs in PBS, tissues were serial 
diluted and plated on THA plates. Also blood was collected, diluted and plated. 
Bacterial loads found in different tissues in wt- and ΔBP-1-injected groups were 
similar, while instead there was a significant decrease in bacterial load in both the 
tissues and blood of mice infected with BP-PI-2b mutant (Fig. 32A). These 
findings demonstrated the important role of type 2b pilus in in vivo infection since 
its deletion affected GBS ability to survive and infect host tissues. 
In order to better clarify different pili contribution to BBB penetration, an in vitro 
blood survival assay was performed. In this way we could understand if the 
differences of bacterial load found in blood and tissues of infected mice were due 
to different strains growth defects.  
Fresh mice blood was collected and heparinized and it was then incubated at 37°C 
for 7 hours with bacteria at an MOI of 0.1. For each strain, three tubes were used 
for every time point collected. 
Samples were then serial diluted in PBS and plated on THA every 30 min, and 
plates were then incubated over-night at 37°C. Mutant strains exhibited equivalent 
growth kinetics to the WT parent strain in murine whole blood ex vivo, thus 
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suggesting that the three strains tested did not have growth defects in blood (Fig. 
32B).  
Taken together these findings indicate that in COH1 strain type 2b pilus is the one 
mostly involved in host infection in in vivo model, confirming the in vitro results 
previously obtained. 
 
 
 
Figure 32. Pilus 2b contributes also to meningitis development in vivo. A) Mice were 
infected i.v. with COH1 wt or with one of the two mutant strains, each one deleted of a 
different BP.  After 2 days mice were sacrificed and blood, brains and lungs were 
collected, homogenized and plated to quantify the bacterial load. As reported, the mutant 
strain deleted of BP-1 did not show any difference from the wild type strain in any of the 
tissues analyzed, while instead the deletion pf BP-2b lead to a significant decrease in the 
bacterial load in all the samples analyzed. B) This difference is not due to ΔBP-2b growth 
defects, since after in vitro blood survival assay, no significant differences among the 
tested strains could be observed. 
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2.2.4 Both pili are important for in vivo vaginal colonization 
 
Our in vitro data indicates that both pilus types alter vaginal epithelial interactions 
(Fig. 30). To confirm these results in vivo, we used a mouse model of GBS 
vaginal colonization already described (113). In rodents, normal flora load and 
novel bacterial colonization ability appear to peak at estrus (114-116). We found 
this to be true in our model of GBS colonization (113). Consequently, we treated 
8-week old CD1 mice with 17β-estradiol one day prior to bacterial inoculation. 
We inserted ~1×107 cfu GBS into the vagina, and on successive days, the vaginal 
lumen was swabbed and recovered bacteria quantified on agar plates to determine 
changes in bacterial load over time. The ΔBP-2b mutant exhibited decreased 
persistence in the vaginal tract by day 6 post-inoculation when compared to WT 
or ΔBP-1 mutant strains, but not in a significant way (Fig. 33). Moreover, at day 
10 we could not observe any difference between all the strains tested, suggesting 
that both the pilus types are important for vaginal colonization. 
 
 
 
Figure 33. Both pilus types contribute to in vivo vaginal colonization. Mice were 
injected in the vaginal lumen with COH1 wt or with one of the two mutant strains, each 
one deleted of a different BP and swabbed everyday. After 10 days we could not detect 
any significant difference, even if a trend could be observed. 
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Chapter 3. Discussion 
 
In Group B Streptococcus (GBS), a major cause of sepsis and meningitis in 
infants, pili have been associated to virulence and pathogenesis of the bacterium 
and discovered as highly immunogenic vaccine candidates (24,45,52). Pili are 
high-molecular-weight (HMW) polymers, visible by electron microscopy as long 
filamentous structures extending out from the bacterial surface. In GBS three 
structurally distinct pilus types have been identified and they are PI-1, PI-2a and 
PI-2b. These pili are heterotrimeric structures, constituted by a major pilus subunit, 
the backbone protein forming the pilus shaft, and two ancillary proteins (APs). 
These pilins are encoded by a pilus genomic island (PI) that includes also two 
class C sortases and a transcriptional regulator.  
Sortase enzymes have a critical role in Gram-positive bacteria pathogenesis due to 
their function to covalently link to the bacterial cell-wall surface proteins or pilus 
polymers. Because of the importance of their substrates for a successful bacterial 
infection, sortases represent an attractive antivirulence/therapeutic target.  
In this work we explored the sortase-mediated mechanism of pilus type 2b 
biogenesis in Group B Streptococcus, showing that it differs significantly from the 
current model of pilus assembly in Gram-positive pathogens.  
Pilus-associated sortases, classified also as class C sortases (SrtC), are a family of 
membrane-associated cysteine transpeptidases, broadly distributed in Gram-
positive bacteria that function as pilin polymerases that construct multi-subunit 
pili on the cell surface to promote bacterial adhesion (58,79). Unlike the 
constitutively expressed sortase A (SrtA), which normally anchors most surface 
LPXTG-containing proteins to the cell wall (117), SrtC enzymes are predicted to 
target a much smaller set of substrates. Their genes are present in several copies in 
a genome and differently from srtA gene, which is present in a monocistronic 
operon, occur typically in operons located in pathogenicity islands that also 
encode their substrates. The main novelty of this work is that the assembly 
mechanism that we propose for GBS pilus type 2b appears non-canonical. The 
genomic pilus 2b island (PI-2b) codes for two sortases (SrtC1 and SrtC2) in 
addition to three structural subunits. We show that only SrtC1-2b is involved in 
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pilus protein polymerization, while SrtC2-2b does not act as a pilin polymerase, 
but it is involved in pilus anchoring process by recognizing the minor pilin 
subunit. This subunit (AP2-2b) is not conversely recognized by the housekeeping 
SrtA as happens for the pilus assembly in the majority of Gram-positive bacteria. 
By contrast, the classical model deriving from studies of the archetype SpaA-type 
pili in Corynebacterium diphtheriae (55) outlines two basic steps of pilin proteins 
polymerization catalyzed by a class C-sortase followed by the cell wall anchoring 
step of the resulting polymer by the housekeeping SrtA (56). Previous data 
indicated that also the other two pilus types of GBS (pilus 1 and 2a) follow this 
“canonical” assembly model and that both  two sortases C (SrtC1 and SrtC2) 
coded by the genomic pilus islands 1 and 2a (PI-1 and PI-2a) can efficiently 
polymerize the backbone proteins in vivo,  showing a certain level of redundancy. 
Their substrate specificity appeared to be related to their ability to predominantly 
incorporate into pili one of the two ancillary subunits, with significantly reduced 
ability to incorporate the other one (50). Accordingly, genetic and biochemical 
studies showed that the cell-wall anchoring of polymerized pili is completed by 
the housekeeping SrtA (59,92). Therefore, although the three GBS pili appear 
structurally highly similar as well as the overall gene organization of the genomic 
pilus islands, the only pilus type 2b follows a unique assembly mechanism. In C. 
diphtheriae, which produces three distinct pilus structures, SpaA-, SpaD- and 
SpaH-type pili, it has been demonstrated that the cell-wall attachment of Spa-type 
pili is mediated by the housekeeping sortase (named SrtF). Nevertheless, when the 
constitutive SrtF is absent, a class C sortase that is “normally” responsible for 
pilin polymerization, can be activated to catalyze the polymerized pili anchoring 
step, although less efficiently than SrtF (118). Not relatively to pili assembly, 
other studies reported that under specific environmental conditions class B or C 
sortases are activated for targeting proteins to the cell wall (80); for example, in 
sporulating Bacillus anthracis under iron starvation conditions a sortase B enzyme 
is activated for the cell-wall anchoring of a heme-binding protein involved in 
uptake of iron; or a sortase C enzyme can anchor a surface polypeptidide to the 
bacterial cell wall envelope for the formation of infectious spores (117,119,120). 
Similar evidences have been reported in Streptococcus pyogenes, where a class C 
sortase (SrtC2) is in competition with SrtA for protein cell wall anchoring (119). 
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However, the data reported so far on sortases action mechanism, sometimes 
apparently controversial and discrepant highlighted  the universality of the 
transpeptidation mechanism of all sortase members belonging to different families 
and their redundancy and promiscuity in substrate recognition. 
 
To better explore the different role of SrtC1 and SrtC2 in GBS pilus 2b assembly 
we conducted additional analysis by comparing these sortases with other 
characterized pilus-related sortases in Gram-positive species both at the sequence 
and structural level. Compared with GBS pilus 1 and pilus 2a sortases, pilus 2b 
sortases revealed a very low percentage of amino acid identity, forming a cluster 
far away from the others (91). However, at sequence level the most significant 
peculiarity of both SrtC1-2b and SrtC2-2b is the lack of the conserved DPY\W\F 
residues in the N-terminal regulatory lid motif. Moreover, in SrtC2-2b the N-
terminal region is significantly shorter compared to the other, and more, this 
enzyme lacks also the predicted C-terminal transmembrane helix, that is known to 
be required for an efficient protein polymerization in pilus 2a formation (91). 
These observations led us to speculate different mechanisms of activation and 
regulation of these enzymes.  
 
Currently, the presence of an N-terminal lid loop has been considered a 
characteristic feature of all pilus-specific sortases. Interestingly, except for SrtC1 
from S. pneumoniae the poor electron density for most of the main and side chains 
of residues located within the lid (with the exception of the DPY\W\F residues) in 
the majority of SrtC structures indicated a high flexibility of this loop This 
flexibility has been correlated with an important role of the lid in enzyme 
activation, specifically in the regulation of substrate accessibility to the active site 
(91,93-96). Recent data on GBS pilus 2a sortase C1 strongly supported the 
hypothesis that SrtC are auto-inhibited by the presence of the lid and that their 
catalytic activity can be induced through a displacement of this loop from the 
enzyme active site probably as a result of the interaction with the substrate 
proteins and/or other unknown factors (121). It has been recently showed that an 
efficient polymerization of the backbone protein of pilus 2a can be achieved in 
vitro by using a recombinant mutant SrtC enzyme carrying a single residue 
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mutation in the lid region, whereas the wild type enzyme was totally inactive. 
This data suggested that a single residue in the lid can regulate the sortase 
catalytic activity through its interaction with the catalytic cysteine the in the active 
site. The absence of this lid residue might break this interaction, making the active 
site available for substrate binding. Additional analysis revealed that the lid 
confers thermodynamic and proteolytic stability to the sortase enzymes (121). 
SrtC1-2b has a tryptophan residue (W78) that could act as the putative regulatory 
residue by interacting with the catalytic cysteine in the enzyme active site. 
Interestingly, all the residues from S74 to D87 of the lid region in the N-terminal 
α helical roof surrounding the conserved β-barrel core could be included in SrtC1-
2b structure, whereas other structures showed gaps. This might indicate that the 
conformation of SrtC1-2b N-terminal region is more stable. Moreover, this region 
is structurally different in terms of position relative to the β-barrel core; the lid 
loop is displaced from the active site and does not cover the substrate binding 
groove, thus resulting is in a wide-open state, suggesting a possible different 
mechanism for the substrate to gain access to the catalytic core. Except for the lid 
region, the overall fold of SrtC1-2b resembles the previously reported sortase C 
structures, particularly in the β-barrel core region, where the catalytic triad 
perfectly and spatially is overlapping among structures. However, since SrtC1-2b 
structure is in an open conformation, the role of the hypothetical lid residue W78 
in enzyme regulation cannot be confirmed. Interestingly, superimposition of 
SrtC1-2b structure onto the “open-form” structure of sortase C1  from S. suis (98), 
indicated that S. suis SrtC1 is in an even more open conformation than SrtC1-2b. 
Hence, we could speculate that the lid region is capable of exploring wide 
conformational space, going from all the way up (S. suis SrtC1-like conformation) 
to a closed state (S. pneumoniae SrtC1-like or GBS SrtC1-1-like conformation) 
passing through an ”open-intermediate” form as observed in SrtC2-2b 
conformation.  
Another aspect on the sortase activity regulation in vivo takes into account the 
involvement of chaperone-like proteins in pilus assembly. An example is provided 
in pilus polymerization in S. pyogenes, where genetic evidences have 
demonstrated that the sortase  is not sufficient alone to polymerize the backbone 
protein Spy0128, being the signal peptidase-like protein SipA, coded by the same 
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genomic pilus operon, also required for polymers formation (122). Interestingly, 
the crystal structure of Spy0129 revealed that it belongs to class B sortases, with a 
conserved β-barrel core, but lacking of the canonical lid motif as well as of the C-
terminal transmembrane anchor, which is also considered a SrtC typical element. 
The flexibility of the β6/β7 loop is supposed to play a significant role in binding 
the sortase recognition motif of the substrate protein and conformational 
movements in this loop might correlate with the positions and orientations of the 
catalytic Cys and His residues, and be important for enzyme function (123). The 
need of a peptidase-like protein as chaperone for pilus assembly in vivo may be 
common to other pilus systems in the regulation of sortase activity. Interestingly, 
other pilus gene clusters contain genes encoding peptidase-like proteins, i.e. in 
Actinomyces naeslundii (124), in S. pneumoniae (125) and in S. suis (126) as well 
as the genomic pilus island 2b contains a gene coding for a LepA-type signal 
peptidase. Further efforts will be necessary to understand the role of this protein in 
pilus 2b assembly. 
An alternative mechanism could instead regulate the enzymatic activity of SrtC2-
2b. As S. pyogenes Spy0129, SrtC2-2b does not contain a canonical lid region and 
the C-terminal TM, but it carries two additional cysteine residues that we 
speculated could be involved in the regulation of the enzymatic activity by 
disulfide bonds formation. FRET and AMS assays performed with cysteine single 
mutants of the recombinant SrtC2-2b protein suggested that disulfide bonds 
between the catalytic C180 and C115 could suppress the SrtC2 activity in vitro. 
Given that class C sortases are involved in a highly regulated process, we 
supposed that SrtC2-2b activation could be controlled by a redox regulation 
mechanism involving its three cysteines. We could speculate a model where C192 
act as a sortase regulator, since it could be involved alternatively in disulfide 
bonds both with C180 and with C115. Although this hypothesis fits also with the 
SrtC2 structure model obtained by homology modeling, it remains to be further 
confirmed by additional structural studies. 
 
In conclusion, sortase enzymes have a critical role in Gram-positive bacteria due 
to their function to covalently link to the cell-wall surface proteins or pilus 
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polymers,  associated to virulence and pathogenesis of the bacterium (52). 
Importantly, in GBS pilin structural components have been discovered as highly 
immunogenic vaccine candidates and all epidemiologically relevant clinical 
isolates express at least one pilus type (24,45,52,127). Therefore, because of the 
importance of their substrates for a successful bacterial infection, sortases could 
represent an attractive antivirulence/therapeutic target. Thus, fully understanding 
the molecular basis of the mechanism of pilus biogenesis at the membrane 
environment during the establishment and persistence of infections by Gram-
positive microorganisms, trying to solve open issues, for example why some pili 
are associated with multiple sortases and what determines sortase substrate 
specificity remains of great scientific interest.  
Pilus type 2b remained uncharacterized so far, although it has been associated to a 
hypervirulent clone (ST17-serotype III) responsible of the majority of neonatal 
invasive diseases (24) (28,34,48,49,128).  
The host-pathogen interaction upon GBS infection and invasion of BBB is still 
incompletely understood. Previous studies have identified several GBS virulence 
factors contributing to GBS adherence to and invasion of host cells, including pili, 
Fibronectin binding protein SfbA, Serine rich repeat protein Srr, lipoteichoic acid-
anchoring protein IagA, HvgA and the alpha C protein (APC) 
(40,42,111,112,129-132). But their role at molecular level needs to be further 
determined.   
The importance of pili for GBS virulence has already been demonstrated by 
several studies both in vitro and in vivo, where their subunits have been shown to 
be important for the initial bacterial attachment to the host cell promoting an 
efficient colonization (11,12,40,133-136).  In particular pili are important for 
bacterial invasion that can lead to invasive diseases and then they play also a role 
in promoting resistance to phagocytic clearance (135,137). GBS in fact can cause 
meningitis crossing the BBB after adhesion and invasion of brain endothelium 
(42).  
It has been demonstrated that the three different pilin subunits constituting GBS 
pili have different roles in bacterial infection.  
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The major pilin subunit, the backbone protein, has been shown to contribute to 
invasion by promoting resistance to phagocyte killing, thus increasing GBS 
bloodstream survival (135,137). 
The tip ancillary protein (AP1) on the other hand has been demonstrated to be 
involved in adhesion to human pulmonary epithelial cells (11,134,138) or to 
human brain endothelial cells (40,75,137). In particular AP1 binds to collagen 
which promotes GBS interaction with the host thus activating the immune system 
and promoting bacterial entry into the CNS (40). However, the majority of these 
studies have been carried out on pilus types 1 or 2a. 
In this study, we investigated the function of both type 1 and type 2b pilus using 
COH1 as background, a strain belonging to the serotype III-ST 17 lineage.  COH1 
expresses both pilus 1 and 2b and deleting individually BPs, we obtained two 
different strains expressing just one pilus. (62). In this way these knockout 
mutants represented a perfect tool to analyze the role of each pilus in host 
adherence and invasion. 
Previous studies have shown that the capacity of a COH1 BP-1 mutant strain, 
not expressing pilus 1 on its surface, to adhere to epithelial cells was not affected. 
The COH1 AP1-1 mutant strain lacking the gene coding for the AP1 protein 
instead bound significantly less to epithelial cells compared to the wild type, 
suggesting that in pilus type 1 the ancillary protein AP1 seems to have a role for 
pili adhesion to host cells. Type 2b pilus subunits role in adherence were never  
investigated in a ST-17 background (139). 
 
Our findings demonstrate that the BP-2b mutant resulted in a dramatic decrease 
in adherence and invasion to different cell lines, whereas the BP1 mutant strain 
did not show any significant difference in adherence and invasion compared with 
the wild-type strain in hBMEC and lung epithelial cells. Accordingly with our 
results, it was previously reported that the BP-1 mutant  did not impair GBS 
adherence not only to lung epithelial cells, but also to intestinal cell line (Caco2) 
and human cervical epithelial cells (ME180) (139).  
However, BP-1 mutant strain does show significant differences in adherence to 
vaginal epithelial cells compared with the wild-type strain, suggesting that pilus 
proteins function may depend on specific characteristics of host cells (42) since 
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these results were also confirmed by the in vivo vaginal colonization model. 
Indeed it has been reported that the acidic pH of the vaginal tract enhances type 1 
pilus expression [51]. 
Another study instead showed that a BP-1 mutant did not appear to contribute 
significantly to vaginal epithelial cell adherence (140), however, this analysis was 
not performed on a COH1 background, suggesting that results could be influenced 
also by the tested GBS strain. 
In previous studies the BP-2b mutant strain resulted in a decreased adherence 
and invasion to A549, ME-180, C2Bbe1 colonic, and HeLa cervical epithelial 
cells (135,136), in agreement to our evidences. 
Our data also show that both type 1 and type 2b pilus are involved in ECM 
components binding suggesting that pili promote GBS attachment to host cells 
through binding to ECM components. Indeed it has been previously reported that 
PI-AP1 interacts with fibronectin and fibrinogen (75), but also with collagen,  
which engages integrins and the integrin-signaling machinery that contributes to 
the pathogenesis of meningitis in vivo (141). 
Since ECM components and fibronectin have been demonstrated to be on brain 
endothelium (42) we investigated if this binding could be an initial step for BBB 
penetration and meningitis development. 
From our in vivo studies we observed that type 2b pilus contributes to GBS 
virulence and BBB penetration in vivo. In the mouse meningitis model, bacterial 
counts in blood and tissues from mice injected with BP-2b mutant were 
significantly lower in comparison with those from mice injected with the wild-
type or BP-1 mutant. Of note, ex vivo blood survival did not show difference 
among GBS wild-type strain and the two mutant strains indicating the reduced 
virulence from BP-2b mutant is not due to growth defect.  
In summary our data highlight importance of type 2b pilus in GBS attachment and 
invasion of host cell and its contribution to GBS virulence in vivo, suggesting that 
this pilus type so far poorly characterized, should be further investigated. 
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Chapter 4. Experimental procedures 
 
4.1 Bioinformatics 
 
The complete genome sequences of Streptococcus agalactiae strain COH1 are 
available in NCBI GenBank under the Accession Number HG939456.1. The 
primary sequences of SrtC1 protein (accession number CDN66744) and SrtC2 
protein (accession number CDN66742) were used in TMHMM Server 
(http://www.cbs.dtu.dk/services/TMHMM/) to predict transmembrane helices and 
membrane topology of protein sequences. Multiple sequence alignments were 
performed using ClustalW and alignment analyses were done with ESPript 
(http://espript.ibcp.fr/ESPript/ESPript/) (142). 
 
4.2 Bacterial strains, media, and growth conditions 
 
Group B Streptococcus strains (Suppl. Table 1) were grown in Todd Hewitt Broth 
(THB) or trypticase soy agar (TSA) plates or chemically defined RPMI-1640 
medium (Sigma-Aldrich) at 37°C in 5% CO2. Escherichia coli cells were grown 
aerobically at 37°C in Luria-Bertani medium. When required, antibiotics were 
added to the medium at the following concentrations: erythromycin, 1 µg/ml (S. 
agalactiae) or 100 µg/ml (E. coli); chloramphenicol, 10 µg/ml (S. agalactiae) or 
20 µg/ml (E. coli), ampicillin 100 µg/ml (E. coli). 
 
4.3 DNA manipulation  
 
Genomic DNA was isolated from GBS strains by a standard protocol for Gram-
Positive bacteria, by mutanolysin-treatment of bacterial cells using a GeneElute 
Bacterial Genomic DNA kit (Sigma-Aldrich) according to the manufacturer’s 
instructions. Plasmids (Suppl. Table 1) were purified from E. coli cells using a HP 
Plasmid Miniprep Kit (Omega Bio-Tek, VWR). DNA restriction and modification 
enzymes were used under the conditions specified by the manufacturer (NEB, 
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Ipswich, MA). Oligonucleotides used in this study were synthesized in-house or 
by Sigma-Aldrich. PCR experiments were performed using Kapa HiFi DNA 
polymerase (KapaBiosystems) and PCR products were purified using the Wizard 
SV Gel/PCR Clean-Up System (Promega).  
 
4.4 Construction of in-frame deletion mutant strains, complementation vectors 
and site-specific mutagenesis 
 
In-frame deletion mutant strains, listed in Suppl. Table 1, were generated in GBS 
strain ABC020017623 carrying only pilus island 2b, using Splicing by Overlap 
Extension (SOE) PCR as described previously (50,143). For each mutant strain 
generated, two PCR products comprising the flanking sequences of the target gene 
and a 30 bp overlapping region, were ligated via the overlap sequence and cloned 
into the temperature-sensitive allelic exchange vector pJRS233 (gift of June Scott, 
Emory University, Atlanta, GA), generating pJRS233-derived plasmids carrying 
overlapping flanking sequences of each target gene to knock out. Transformation 
and allelic exchange were then performed as described previously (144) and 
confirmation of the predicted insertions was obtained by PCR amplification and 
sequencing.  
Complementation vectors (Suppl. Table 1) were generated into the E. coli-
streptococcal shuttle vector pAM401/gbs80P_T, previously described (50,145) 
containing the promoter and terminator regions of the gbs80 gene (TIGR 
annotation SAG_0645). For the generation of vectors pAM_srtC1, pAM_srtC2 
and pAM_AP2-2b, DNA fragments corresponding to srtC1, srtC2 and ap2 genes 
were PCR amplified from GBS strain ABC020017623 genomic DNA and the 
products were cloned into the shuttle vector pAM401/gbs80P_T. 
For the generation of the complementation vector pAM_BP-2b, a DNA fragment 
corresponding to BP-2b gene (locus tag SAK_1440) was PCR amplified from 
GBS A909 genome, and the product was cloned into the same shuttle vector.  
Site-directed mutagenesis was performed by the polymerase incomplete primer 
extension (PIPE) method (146), using the complementation vectors pAM_SrtC1, 
pAM_SrtC2 and pAM_BP-2b as templates for the introduction of specific 
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mutations. The method was improved using Kapa HiFi polymerase and digesting 
DNA template with DpnI enzyme to optimize the protocol for large plasmids. 
Mutations were confirmed by DNA sequencing. All complementation vectors 
expressing mutated forms of sortases were electroporated into the corresponding 
knock-out (KO) strains. Complementation was confirmed by checking protein 
expression by Western blot analysis.  
 
4.5 Antibodies 
 
Antisera specific for the pilus 2b subunits, backbone protein (BP-2b), major and 
minor ancillary proteins (AP1-2b and AP2-2b) and sortases C were produced by 
immunizing CD1 mice with the purified recombinant proteins as previously 
reported (24,50). Animal treatments were performed in compliance with current 
Italian legislation on the care and use of animals in experimentation (Legislative 
Decree 116/92) and with the Novartis Animal Welfare Policy and Standards. 
Protocols were approved by the Italian Ministry of Health (authorization 21/2009-
B) and by the local Novartis Animal Ethical Committee (authorization AEC 
200825).  
Mouse monoclonal antibodies (mAbs) anti BP-1, anti BP-2a, anti BP-2b and anti 
polysaccharide III (PS-III) were generated by Areta International (Varese, Italy) 
using standard protocols. Briefly, B-cell hybridoma clones were isolated from 
spleen cells of immunized CD1 mice with the purified recombinant proteins (BP-
1, BP-2a and BP-2b) and the purified tetanus toxoid (TT)-conjugated serotype III 
polysaccharide. Hybridoma clones were screened by enzyme-linked 
immunosorbent assay (ELISA). Positive clones were then tested for binding to the 
surface of GBS by flow cytometry. The selected mAbs were finally purified by 
protein G affinity chromatography. and the MAbs were purified by protein G 
affinity chromatography. 
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4.6 GBS proteins extraction and immunoblot analysis 
 
For the preparation of total soluble proteins GBS mid-exponential-phase cells, 
grown in THB or RPMI, were harvested by centrifugation, washed in phosphate-
buffered saline (PBS) and re-suspended in 50mM Tris-HCl (pH 6.8), containing 
mutanolysin (Sigma-Aldrich, St. Louis, MO, USA) and complete protease 
inhibitors (Roche, Basel, Switzerland). Cell suspensions were incubated at 37°C 
for 2 hours. After 3 cycles of freeze and thaw, total soluble proteins were 
separated from insoluble materials by centrifugation at 15000 g at 4°C for 10 min. 
The pellet corresponding to the membrane-enriched fraction was solubilized in 2% 
SDS buffer and used for assessing sortase expression. To visualize proteins 
released during bacterial growth, supernatants from cultures in RPMI medium 
were harvested by centrifugation at 4,000 g for 20 min, filtered with a 0,22 µm 
syringe filter and 10-fold concentrated. Protein concentration was measured using 
BCA protein assay (Pierce; Thermo Scientific, Rockford, IL, USA). 
Equal amounts of bacterial proteins from each strain were separated by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
to nitrocellulose membranes using iBlot transfer (Dry blot system, 
Lifetechnologies). Membranes were probed with mouse antisera directed against 
structural pilus proteins or against sortase C enzymes (1:1000 dilution), followed 
by a rabbit anti-mouse horseradish peroxidase-conjugated secondary antibody 
(Dako, Glostrup, Denmark). Bands were then visualized using an Opti-4CN 
substrate kit (Bio-Rad) or SuperSignal West Pico chemiluminescent substrate 
(Pierce; Thermo Scientific, Rockford, IL, USA). 
 
4.7 Cloning, expression, and purification of recombinant proteins 
 
PCR fragments encoding SrtC138-245 (locus tag GBSCOH1_1278) and SrtC232-199 
(locus tag GBSCOH1_1276) domains were amplified by PCR from genomic 
DNA extracted from the COH1 GBS strain and cloned into pET15-TEV vector 
(modified in house from Novagen to adapt to PIPE cloning) using the polymerase 
incomplete primer extension (PIPE) method (146) to produce N-terminal HIS-
76 
 
tagged (TEV cleavable) proteins. The SrtC2C115A, SrtC2C180A, and SrtC2C192A  
mutants were generated by PIPE site-directed mutagenesis using as template the 
HIS-tagged SrtC232-199  wild type plasmid. The recombinant SrtA was produced as 
previously reported (92) and AP2-2b (locus tag GBSCOH1_1277) was cloned in 
pET21b(+) vector to produce a C-terminal HIS-tagged protein following the same 
strategy reported for AP2-2a (92). 
Protein expression was performed in Escherichia coli Rosetta2(DE3) cells 
(Novagen) using the EnPresso Tablet Cultivation Set (BioSilta) supplemented 
with 100 μg/mL ampicillin. Bacteria were first grown at 30°C, 160rpmfor 12 
hours and afterwards target protein production was induced by the addition of 
1mM IPTG at 25°C, 160rpm for 24 hours. Cells were harvested by centrifugation 
(4000 rpm, 30 min, 4°C), and then cell lysis were performed using Cell Lytic 
Express (Sigma Aldrich). Protein purification was performed by a first 
immobilized metal affinity chromatography (IMAC) step followed by a second 
IMAC step after TEV cleavage to remove the N-terminal 6XHis-tag. 
 For the purification of SrtC1WT and SrtC2WT used for crystallization trials the last  
IMAC purification step was followed by size-exclusion chromatography (SEC) 
using HiLoad 26/60 Superdex 200 (GE Healthcare; Life Sciences, Piscataway, NJ, 
USA) equilibrated in 25 mM HEPES,75 mM NaCl pH7 at a flow rate of 2 ml/min. 
The fractions containing the pure protein, which showed a single band by SDS-
PAGE, were quantified with the bicinchoninic acid (BCA) assay (Pierce; Thermo 
Scientific, Rockford, IL, USA). 
For NMR experiments cells were grown in M9 minimal medium containing 1 g/l 
of (15NH4)2SO4 for the expression of 15N labeled samples, at 37°C until OD600 ~ 
0.8 and then induced with 1 mM isopropyl-β-d-thiogalactoside for 16 h at 25°C. 
The soluble proteins were extracted using CelLytic B (Sigma-Aldrich) and DNase 
and then  purified by a FF-Crude His-Trap HP nickel chelating column 
(Amersham Biosciences, Piscataway, NJ, USA). The recombinant SrtC2 mutants 
were eluted with 300 mM imidazole, and the buffer was exchanged with TEV 
cleavage buffer (50 mM Tris-HCl, pH 8; 1 mM DTT, and 0.5 mM EDTA) using a 
PD-10 desalting coloumn  (GE healthcare). HIS-tag was cleaved by incubation 
with AcTEV protease (12h at RT) and then removed by a subtractive IMAC 
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purification step. The proteins were then concentrated by ultrafiltration to 20 
mg/ml, and the buffer was exchanged using a PD-10 desalting column 
(Amersham Biosciences) equilibrated with 50mM NaH2PO4 pH 6.5. 
 
4.8 Crystallization, data collection and structure determination 
 
Crystallization experiments were performed by the sitting-drop method, mixing 
0.2 µL of protein at 30 mg/ml and 0.1 µL of reservoir solutions in 96-well low-
profile crystallization plates and using a Crystal Gryphon robot (Art Robbins 
Instruments). Crystals of SrtC1-2b were obtained in condition H2 of the Hampton 
Research PEG/ION screen, containing 0.05M tri-Sodium Citrate (pH 2.3), 16% 
PEG3,350, 0.05M Bis-Tris propane (pH 9.7). Before data collection, crystals of 
SrtC1-2b were first soaked in 10% ethylene glycol as cryoprotectant, and then 
cooled to 100 K in liquid nitrogen.  
Diffraction data were measured at 100K on beamline ID29 of the European 
Synchrotron Radiation Facility (ESRF) in Grenoble, and processed with XDS 
(147) and the CCP4 suite of programs (148). The structure of SrtC1-2b was 
solved by molecular replacement in molrep (149), using coordinates of the sortase 
C1 of the pilus island 1 of GBS (pdb ID 4g1j) as input template model. Structure 
refinement and rebuilding were performed by Phenix (150), and Coot (151), with 
final model Rwork and Rfree statistics of 18.0 and 22.3 %, respectively. The final 
refined coordinates of SrtC1 includes residues 39-232, and were deposited in the 
PDB with accession code 4d7w. Data collection and refinement statistics are 
summarized in Table 4. 
 
4.9 Nuclear magnetic resonance (NMR) spectroscopy 
 
15N labeled recombinant protein sample were buffer exchanged using a PD-10 
desalting column (Amersham Biosciences, Arlington Heights, IL, USA), 
equilibrated with 50 mM phosphate buffer (pH 6.5), and finally concentrated by 
ultrafiltration to 0.3 mM.  
78 
 
Next, 1H-15N heteronuclear single-quantum coherence (HSQC) spectra were 
recorded at 25°C on a Bruker Avance III spectrometer (Bruker, Karlsruhe, 
Germany) operating at 600.13 MHz proton Larmor frequency, equipped with a 
cryogenic probe. A standard 1H-15N HSQC pulse sequence was used, with pulsed 
field gradients for suppression of the solvent signal and cancellation of artifacts. 
Next, 2048 (1H) × 256 (15N) complex data points were acquired with spectral 
windows of 8196.935 Hz (1H) ×2432.718 Hz (15N), 8 transients, and 1.2-s 
relaxation delay. Proton T2 measurements were performed with the 1D oneone 
echo sequence (152) using variable delays of 0.2 and 5.2 ms and evaluating the 
corresponding signal intensities [T2 =2 × (5.2 - 0.2)/ln (I0.2/I5.2)]. Processing of all 
the spectra was performed with Topspin2.1 (Bruker, Karlsruhe, Germany). 
 
4.10 Fluorescence resonance energy transfer (FRET) assay 
 
The Fluorescence resonance energy transfer (FRET) assay was used to monitor 
the in vitro activity of the recombinant sortase enzymes by using fluorescently 
self-quenched peptides, tagged with EDANS as fluorophore and DABCYL as 
quencher, containing the LPXTG-like motif of pilin subunits (Table 3). The 
synthetic fluorogenic peptides were purchased from Thermo Scientific 
Biopolymers (Waltham, MA, USA) and were dissolved in 50% DMSO. 
The activity test was performed in 300 mM NaCl, 50 mM Tris-HCl (pH 8), 5 or 
25 µM sortase enzymes, and 64 or 128 µM fluorogenic peptide. Reaction was 
started by the addition of enzyme and was monitored by measuring the increase in 
fluorescence every 20 min (λex=336 nm, λem=490 nm) at 37°C using an 
InfiniteM200 spectrophotometer microplate reader (Tecan, Mannedorf, 
Switzerland). Measurements of fluorogenic peptides incubated at the same 
conditions, but without sortases were used as blank. 
 
4.11 In vitro cleavage assay 
 
The in vitro cleavage assay was performed by mixing 50 µM of the recombinant 
SrtC2WT or SrtAWT with 25 µM of the recombinant His-tagged AP2-2b protein. 
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The volume of reaction was 1 ml in buffer containing 50 mM Tris-HCl, 300 mM 
NaCl, and 1 mM DTT (pH 8). DTT was added just to prevent the formation of 
potential disulfide bridges leading to aspecific SrtC2 dimerization during the 
incubation time. As control each protein was incubated alone at the same 
conditions. 
The incubation was performed at 37°C, and the reaction samples were purified by 
IMAC and eluted with 300 mM imidazole. The concentration of the purified 
fractions was then measured with BCA assay and then equal amount of each 
sample was analyzed by Western blot analysis using sera anti-AP2-2b. 
 
4.12 Free-cysteines quantification 
 
Estimation of free thiols was performed by AMS (4-acetamido-4_-
maleimidylstilbene-2,2_disulfonic Acid) to study if the  cysteines oxidation state 
is or not involved in disulphide bonds formation. AMS has high water solubility 
and readily is conjugated to free thiols (108). 
Recombinant SrtC2 wt and SrtC2C115A, SrtC2C180A, and SrtC2C192A  mutants were 
purified by two steps of IMAC and TEV cleavage. All the protein samples were 
quantified through BCA assay and checked by SDS_PAGE. Half of the samples 
(reduced form) were incubated with 5 mM DTT for 15’ at 37°C,   buffer was then 
exchanged through PD-10 to remove the DTT. The other half of the samples (non-
reduced form) was directly incubated incubated with AMS without any DTT 
treatment.  
Samples of 1 ml of the reaction mixture in 50 mM Tris-HCl, 300 mM NaCl buffer 
(pH 8) containing 25 μM protein, 250 μM AMS, and 1% SDS were incubated for 
30 min at 37°C to complete the reaction. The excess of AMS was removed by 
dialysis.  
AMS shows a typical UV absorption at ≈328 nm and emission maximum at 408 
nm. Fluorescence measurements (λ excitation=322 nm; λ emission=406 nm) were 
performed to detect the AMS bounded to the free thiols present in each protein 
samples at the moment of the AMS addiction to evaluate the difference in the 
number of free thiols between reduced and native forms of the wild type and 
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cysteine-mutated sortases. The same buffer only with AMS and without sortase 
was used as blank. 
 
4.13 Flow cytometry 
 
GBS was grown in THB and stopped at OD 0.5 and after a wash with PBS, 
harvested bacterial cells were resuspended in PBS containing 0.1% (wt/vol) 
paraformaldehyde. Cell suspensions were incubated at 37°C for 1 h. Fixed cells 
were then washed in PBS/1% BSA and incubated at RT for 20 min in newborn 
calf serum (Sigma, St. Louis, MO). Bacteria were then incubated for 30 min at RT 
with primary antibodies diluted 1:200 in dilution buffer (PBS, 0.1% [wt/vol] 
bovine serum albumin, 20% [vol/vol] newborn calf serum). Monoclonal 
antibodies used were anti BP-1, anti BP-2a, anti BP-2b and anti polysaccharide III 
(PS-III).  Cells were washed in PBS–0.1% (wt/vol) bovine serum albumin and 
incubated for a further 30 min with R-phycoerythrin-conjugated F(ab)2 goat anti-
mouse immunoglobulin G (1:100 dilution) (Jackson ImmunoResearch 
Laboratories, West Grove, PA) diluted 1:100 in PBS containing 0.1% BSA. Cells 
were washed again, resuspended in PBS, and analyzed with a BD FACS Calibur 
(BD Bioscience) by acquiring 15,000 events. FlowJo software (v.8.6, Tree Star, 
Ashland, OR) was used.  
 
4.14 Cell lines 
 
GBS infection assays were performed in both endothelial and epithelial cell lines. 
Immortalized human brain microvascular endothelial cell line (hBMEC) was 
kindly provided by professor Kwang Sik Kim at Johns Hopkins University and 
cells were cultured in RPMI1640 containing 10% FBS, 10% Nu-serum and 1% 
nonessential amino acids.  Immortalized human vaginal (VK2/E6E7) epithelial 
cell line was obtained from the American Type Culture Collection (ATCC CRL-
2616) and was cultured in keratinocyte serum-free medium (KSFM) (Invitrogen) 
containing 0.1 ng.ml_1 human recombinant epidermal growth factor (EGF), 0.05 
mg.ml_1 bovine pituitary extract, and 0.4 nM calcium chloride . Human A549 
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lung carcinoma cell line was obtained from the American Type Culture Collection 
(ATCC CCL-185) and was cultured in RPMI1640 Human A549 lung carcinoma 
cell line was containing 10% FBS, and 1% nonessential amino acids. All cells 
lines were maintained at 37°C with 5% CO2. 
 
4.15 Adherence and invasion assays 
 
For the infection assays  mid-log grown bacteria were added to confluent cell 
monolayers at a multiplicity of infection (MOI) of 1. Total cell-associated GBS 
bacteria were recovered after an incubation of 30 minutes, while intracellular GBS 
were recovered after 2-h infection and 2-h incubation with 100 μg of gentamicin 
(Sigma) and 5μg of penicillin (Sigma) to kill all extracellular bacteria.  After 
washing, monolayers were trypsinized with 0.1 ml of 0.25% trypsin-EDTA 
solution and lysed with addition of 0.4 ml of 0.025% Triton X-100 by vigorous 
pipetting and the number of invasive bacteria was quantified by serial dilution 
plating on THA. Parallel invasion experiments were performed in hBMEC, 
vaginal epithelial cells and A549 lung epithelial cells. Bacterial adherence (total 
cell-associated) and invasion was calculated as (recovered CFU/initial inoculum 
CFU) x100%.  
All cellular adherence and invasion assays were performed in triplicate and 
repeated at least three times. 
 
4.16 Binding of GBS to ECM components 
 
96 well plates were coated with human fibronectin (Sigma), rat tail collagen type I 
(Sigma), human fibrinogen (Acris Antibodies) and laminin from human placenta 
(Sigma) respectively at a concentration of 5μg.ml-1. The assay was performed as 
described previously (42). Briefly ~1×105 CFU of GBS were added into each well 
and incubate for 30 min at 37°C. The wells were then washed with PBS to remove 
unbound bacteria, and adherent bacteria were treated with 50 μL 0.25% trypsin-
EDTA solution for 10 min at 37°C to release the attached bacteria. Bacteria were 
quantified by plating serial dilutions onto THB agar. The percentage of GBS 
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binding to ECM components was calculated as (recovered CFU/initial inoculum) 
×100%. 
 
4.17 Mouse model of meningitis 
 
Animal experiments were approved by the committee on the use and care of 
animals at San Diego State University (SDSU) protocol APF 13-07-011D and 
performed using accepted veterinary standards. We utilized a mouse model of 
hematogenous GBS meningitis that has already been used in Kelly Doran’s lab at 
SDSU (42). Briefly, 8-week-old male CD-1 mice (Charles River Laboratories, 
Wilmington, MA, USA) were injected via tail vein (i.v.) with 1.5×108 CFU of 
GBS. At the experimental endpoint (day 2 p.i.) blood, brain and lungs were 
collected upon euthanasia. Tissues were homogenized and homogenates as well as 
blood were plated on THB agar for enumeration of bacterial CFU.  
 
4.18 Bacteria blood survival assay 
 
4×103 CFU of mid log phase GBS were added into 0.2 ml of heparinized mice 
fresh blood and incubated at 37°C with rotation. The number of viable bacteria in 
the mixture was determined by plating serial dilutions on THA every 30 min up to 
7 hr. Each GBS strain was run in triplicate for each time point. 
 
4.19 In vivo mouse model of vaginal colonization 
 
Female CD1 mice, 8 weeks of age were used for colonization assays (10 mice per 
group) as described previously (113). They were injected intraperitoneally (i.p.) 
with 0.5mg β-estradiol valerate in 100uL of sesame oil (Sigma) to synchronize 
estrus and optimize bacterial colonization 24h prior to GBS inoculation.Mice 
were inoculated with a total ~1x107 CFU of GBS in 10μL of PBS in the vaginal 
vault.WT and the two BP mutant strains were used. In the following days the 
bacterial load was determined by swabbing the vaginal lumen with ultrafine 
calcium alginate-tipped swabs and serial dilution plating of swab samples on 
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CHROMagarStrepBagar (DRGInternational Inc.). These plates allow to identify 
GBS and native Enterococcus strains by the presence of pink- and blue-pigmented 
colonies, respectively.  
 
4.20 Statistical analysis 
 
The significance of differences in bacterial counts between mice groups or in 
hBMEC adherence and invasion was determined using one-way ANOVA. P < 
0.05 was considered to be significant. 
GraphPad Prism (GraphPad Software, San Diego, CA, USA) was used for all the 
analyses. 
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Supplementary tables 
 
Table 1. Bacterial strains and plasmids used in this study 
Strain or plasmid Relevant characteristic(s) 
Source or 
reference 
Strains   
    E. coli   
        Rosetta F– ompT hsdSB(rB– mB–) gal dcm pRARE2 (CamR) Novagen 
        DH5α F- φ80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, 
mk+) phoA supE44 λ- thi-1 gyrA96 relA1  
Invitrogen 
        Mach1™-T1R F- φ80(lacZ)∆M15 ∆lacX74 hsdR(rK-mK+) ∆recA1398 endA1 tonA Invitrogen 
   
    S. agalactiae   
ABC020017623  Wild type (24) 
ABC020017623∆BP GBS knockout (KO) deleted of  pilus 2b backbone protein gene (153) 
ABC020017623∆BP + BPwt ∆BP complemented with pAM401_BPWT This study 
ABC020017623∆BP + BPΔLPXTG ∆BP complemented with pAM401_BPΔLPXTG This study 
ABC020017623∆BP + BPE423A ∆BP complemented with pAM401_BPE423A This study 
ABC020017623∆BP + BPK77A ∆BP complemented with pAM401_BPK77A This study 
ABC020017623∆BP + BPK82A ∆BP complemented with pAM401_BPK82A This study 
ABC020017623∆BP + BPK118A ∆BP complemented with pAM401_BPK118A This study 
ABC020017623∆BP + BPK175A ∆BP complemented with pAM401_BPK175A This study 
ABC020017623∆SrtC1 GBS knockout (KO) deleted of  pilus 2b sortase C1 gene This study 
ABC020017623∆SrtC1 + SrtC1wt ∆SrtC1 complemented with pAM401_SrtC1WT This study 
ABC020017623∆SrtC1 + 
SrtC1C188A 
∆SrtC1 complemented with pAM401_SrtC1C188A This study 
ABC020017623∆SrtC2 GBS knockout (KO) deleted of  pilus 2b sortase C2 gene This study 
ABC020017623∆SrtC2 + SrtC2wt ∆SrtC2 complemented with pAM401_SrtC2WT This study 
ABC020017623∆SrtC2 + 
SrtC2C115A 
∆SrtC2 complemented with pAM401_SrtC1C115A This study 
85 
 
ABC020017623∆SrtC2 + 
SrtC2C180A 
∆SrtC2 complemented with pAM401-SrtC1C180A This study 
ABC020017623∆SrtC2 + 
SrtC2C192A 
∆SrtC2 complemented with pAM401-SrtC1C192A This study 
ABC020017623∆AP2 ∆AP2 Unpublished 
data 
ABC020017623∆AP2 + AP2 ∆AP2 complemented with pAM401-AP2 This study 
COH1 Wild type (50) 
COH1∆BP-1 GBS knockout (KO) deleted of  pilus 1 backbone protein gene (50) 
COH1∆BP-1 + BP-1 ∆BP-1 complemented with pAM401-BP-1 (50) 
COH1∆BP-2b GBS knockout (KO) deleted of  pilus 2b backbone protein gene Unpublished 
data 
COH1∆BP-2b + BP-2b ∆BP-2b complemented with pAM401-BP-2b This study 
Plasmids   
     pJRS233 6.0 kb; ColE1 ori; temperature-sensitive E. coli-streptococcal shuttle 
vector 
(154) 
     pJRS233_∆SrtC1 pJRS233-derived containing overlapping flanking sequences of 
SrtC1 gene 
This study 
     pJRS233_∆SrtC2 pJRS233-derived containing overlapping flanking sequences of 
SrtC2 gene 
This study 
     pAM401/gbs80P+T 11.5 kb; Cmr; ColE1 ori; E. Coli-streptococcal shuttle vector 
pAM401 containing promoter of gbs80 
(50) 
. .  pAM401_SrtC1WT pAM401/gbs80P+T-derived containing entire SrtC1WT coding 
sequence 
This study 
. .  pAM401_SrtCC188A pAM401/gbs80P+T-derived containing entire SrtC1C188A coding 
sequence 
This study 
..   pAM401_SrtC2WT pAM401/gbs80P+T-derived containing entire SrtC2WT coding 
sequence 
This study 
     pAM401_SrtC2C115A pAM401/gbs80P+T-derived containing entire SrtC2C115A coding 
sequence 
This study 
 ..  pAM401_SrtC2C180A pAM401/gbs80P+T-derived containing entire SrtC2C180A coding 
sequence 
This study 
 ..  pAM401_SrtC2C192A pAM401/gbs80P+T-derived containing entire SrtC2C192A coding 
sequence 
This study 
..   pAM401_AP2 pAM401/gbs80P+T-derived containing entire AP2 coding sequence This study 
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     pAM401_BP-2b pAM401/gbs80P+T-derived containing entire BP-2b coding 
sequence 
This study 
pAM401_BP-2bΔLPXTG pAM401/gbs80P+T-derived containing BP-2bΔLPXTG coding sequence This study 
pAM401_BP-2bE423A pAM401/gbs80P+T-derived containing entire BP-2bE423A coding 
sequence 
This study 
pAM401_BP-2bK77A pAM401/gbs80P+T-derived containing entire BP-2bK77A coding 
sequence 
This study 
pAM401_BP-2bK82A pAM401/gbs80P+T-derived containing entire BP-2bK82A coding 
sequence 
This study 
pAM401_BP-2bK118A pAM401/gbs80P+T-derived containing entire BP-2bK118A coding 
sequence 
This study 
pAM401_BP-2bK175A pAM401/gbs80P+T-derived containing entire BP-2bK175A coding 
sequence 
This study 
     pET15-TEV 5708bp; Bacterial expression vector with T7 promoter and N-
terminal TEV-cleavable 6xHis- tag; ampicillin resistance in bacteria; 
restriction enzyme cloning 
Novagen 
     pET15-TEV-Srtc232-199 pET15TEV-derived containing  SrtC232-199 coding sequence This study 
     pET15-TEV-Srtc2C115A pET15TEV-derived containing SrtC2C115A coding sequence This study 
     pET15-TEV-Srtc2C180A pET15TEV-derived containing SrtC2C180A coding sequence This study 
     pET15-TEV-Srtc2C192A pET15TEV-derived containing SrtC2C192A coding sequence This study 
     pET15-TEV-Srtc138-245 pET15TEV-derived containing SrtC1 coding sequence lacking of the 
N- and C-term transmembrane regions 
This study 
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Table 2. Primers used in this study 
	 Sequence 	
petTEVfor  TAACGCGACTTAATTCTAGCATAACCCCTTGGGGCCT
CAAACGG 
Sequencing after cloning in 
pet15 vector 
petTEVrev GCCCTGGAAGTACAGGTTTTCGTGATGATGATGATGA
TGGCTGCTGCCCATGGTATATC 
Sequencing after cloning in 
pet15 vector 
seqpetrev  GATATCCGGATATAGTTCCTC Sequencing after cloning in 
pet15 vector 
npet  CGCGAAATTAATACGACTCAC Sequencing after cloning in 
pet15 vector 
MSrtC2C11
5F 
GTGATTGCGGCGCATAATTTTCCTTATCATTTTGAT Site-directed mutagenesis 
for C115A in SrtC2 
MSrtC2C11
5R 
ATGCGCCGCAATCACCATGTTATTAGTTAAATAAGA Site-directed mutagenesis 
for C115A in SrtC2 
MSrtC2C18
0F 
TTTACTGCGACAAAGGCAGGAGTAGCTAGAGTATTA Site-directed mutagenesis 
for C180A in SrtC2 
MSrtC2C18
0R 
CTTTGTCGCAGTAAACAAGCTTAAGTCCCAATCATT Site-directed mutagenesis 
for C180A in SrtC2 
MSrtC2C19
2F 
GTGCGCGCGCAATTAATTGATGTTAAAAATTAA Site-directed mutagenesis 
for C192A in SrtC2 
MSrtC2C19
2R 
TAATTGCGCGCGCACTAATACTCTAGCTACTCCTGC Site-directed mutagenesis 
for C192A in SrtC2 
MSrtC1C18
8F 
GTGACGGCGACACCATATGGCGTTAATACCCATCGG Site-directed mutagenesis 
for C188A in SrtC1 
MSrtC1C18
8R 
TGGTGTCGCCGTCACCAAAGTTTGGTAGTCTTTACC Site-directed mutagenesis 
for C188A in SrtC1 
SeqSrtC2F ACAAGGTATTATGGTTCTTAT Sequencing of SrtC2 
SeqAP2F ACAAAAGCTGTTCATAAAACT Sequencing of AP2 
SeqSrtC1F TTAAAAGTTGGAGACCACTGG Sequencing of SrtC1 
PSrtC2R AATTAAGTCGCGTTAATTTTTAACATCAATTAATTG Cloning of SrtC2 in 
pet15tev 
PSrtC1F CTGTACTTCCAGGGCGCTTATCCTTCACTTGCTAAT Cloning of SrtC1 in 
pet15tev 
PSrtC1R22 AATTAAGTCGCGTTACTCTATTTGTATTGCCTCTGC Cloning of SrtC2 in 
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2   pet15tev 
SanSrtC1R
EV 
CTCTCTCTGAGATCTTTATAAATCATTGTTCTCTTCC
TTTCT 
Cloning of SrtC1 in PAM 
P5pjrsF GCTATGACCATGATTACGCCAAGC Sequencing of insertion in 
Pjrs 
P6pjrsR GCTTAAATCGGGCCATTTTGCG Sequencing of insertion in 
Pjrs 
P1FSrtC1  CGCGGATCCATGCCATCTGCTTCTGTAGTTGATTTGA
AC 
SrtC1 Ko construction 
P2R SrtC1 ATCGCTCGAGATTGGTGAAATGAATTC SrtC1 Ko construction 
P3F SrtC1 TCACCAATCTCGAGCGATAACGTAAGAAAATTTTAAA
ACAAGCA 
SrtC1 Ko construction 
SrtC1R4sa
l 
CCGGTCGACTTAAGTTCGGAATATCCAGAGTTCCCAA
G 
SrtC1 Ko construction 
P7seq 
SrtC1F  
ATGCCATCTGCTTCTGTAGTTGATTTGAAC  SrtC1 Ko construction 
P8seq 
SrtC1R  
TTTAAAACAAATATAGCACCTTGTAATGAA SrtC1 Ko construction 
P9seq 
SrtC1F  
GAATGCTACGGGTCAATTTCTAAACTTTAA SrtC1 Ko construction 
P10seq 
SrtC1R  
TAAATGTTGTCTTATTTTTTTCATATATTT SrtC1 Ko construction 
P11seq 
SrtC1F  
GTATCCATTTTGCTTGTCACTATAATTGCA SrtC1 Ko construction 
P12seq 
SrtC1R  
AAAGCCTTGAAGAGGGTAAACCTCTATGTC SrtC1 Ko construction 
P13seq 
SrtC1F  
TTTCTGATTTGGATAAGTTAAAAGTTGGAG SrtC1 Ko construction 
P14seq 
SrtC1R  
TACTTAGACTAAATAATAAGAGAAGAGTTA SrtC1 Ko construction 
P15seq 
SrtC1F  
CTCAACTTGTGTCTGCTGATACCAATGATC SrtC1 Ko construction 
P16seq 
SrtC1R  
AGGGCTCATTTTCTCAAATGCTGTAATATC SrtC1 Ko construction 
P17seq 
SrtC1F 
TTAAATGCTAAACCTAAAAAAGAAGAGACA SrtC1 Ko construction 
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P18seq 
SrtC1R  
TTAAGTTCGGAATATCCAGAGTTCCCAAGT SrtC1 Ko construction 
P19ext 
SrtC1F  
ATCATGGTACAGAAAAAGTGTATCAATATG SrtC1 Ko construction 
P20ext 
SrtC1R  
ACAGTTGTTCAAAACTATAATTAGCAGCTA SrtC1 Ko construction 
P1F SrtC2  CGCGGATCCATATGGCGTTAATACCCATCGGTTACTA
GT 
SrtC2 Ko construction 
P2R SrtC2 TAGATTCCAGAACTTACCAGAATAATTCCG SrtC2 Ko construction 
P3F SrtC2  AGGAGTAGCTAGAGTATTCGGAATTATTCTGGTAAGT
TCTGGAA 
SrtC2 Ko construction 
P4R SrtC2  CCGCTCGAGTCAAATGCGATTACAGTGTCGGGCCAAT
AT 
SrtC2 Ko construction 
P5seq 
SrtC2F   
ATATGGCGTTAATACCCATCGGTTACTAGT SrtC2 Ko construction 
P6seq 
SrtC2R   
TATAGTAATAGAACCCGTTTTCATCTGATC SrtC2 Ko construction 
P7seq 
SrtC2F   
AGGTATTGGAATAAAAGACGATGATCTAAC SrtC2 Ko construction 
P8seq 
SrtC2R   
TAATCACGTCTTCTTCTCCATTTTAAAGCT SrtC2 Ko construction 
P9seq 
SrtC2F   
GAAGATATTCAGCAAATTTTTTAGCTATAC SrtC2 Ko construction 
P10seq 
SrtC2R   
TCTATTACTGATTTTGTAGTGATAGATTTG SrtC2 Ko construction 
P11seq 
SrtC2F   
GAAATTATTGAACCAACAGCGATTGAAAAA SrtC2 Ko construction 
P12seq 
SrtC2R   
CATTTTACGTGTATTTGTCATAAAAAAATT SrtC2 Ko construction 
P13seq 
SrtC2F   
GTGACAATCGCCATTCTTTCTGCCTTATCT SrtC2 Ko construction 
P14seq 
SrtC2R   
TTTATATCTTTCTAATATTGGCAAACAAGCCA SrtC2 Ko construction 
P15ext 
SrtC2F  
ATTGTTAAAGGTAAAGACTACCAAACTTTG SrtC2 Ko construction 
P16ext 
SrtC2R  
TAGAAAGATTTGGCAACTGTCCTCTAACAC SrtC2 Ko construction 
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SrtC1 Not 
for 
CACCTGTCATGCGGCCGCATTTTAGTAATAGGAGCAG
GTA 
Cloning of SrtC1 into Pam 
SrtC1 
BglII-rev  
CTCTCTCTGAGATCTTTATAAATCATTGTTCTCTTCC
TTTCT 
Cloning of SrtC1 into Pam 
SrtC2 Not 
for 
CACCTGTCATGCGGCCGCTAATTATGTCAGGACTTC Cloning of SrtC2 into Pam 
SrtC2 Bgl 
rev 
CACCTGTCATAGATCTTTAATTTTTAACATCAATTAA Cloning of SrtC2 into Pam 
AP2 Not 
for 
CACCTGTCATGCGGCCGCAGCAATGAGAAAGGAAGAG
AACAA 
Cloning of AP2 into Pam 
AP2 Bgl 
rev 
CACCTGTCATAGATCTCTAATCACGTCTTCTTCTCCA
T 
Cloning of AP2 into Pam 
pAM-F CGTGACATGACTGAAATAGGTAGTTGAG Sequencing after cloning 
into pam vector 
pAM-R CATCGCCATCTTCAGTTGATTTTAATTGG Sequencing after 
cloning into pam 
vector 
AP2 Not 
for 
CACCTGTCATGCGGCCGCAGCAATGAGAAA
GGAAGAGAACAA 
Cloning of AP2 into 
Pam 
AP2 Bgl 
rev 
CACCTGTCATAGATCTCTAATCACGTCTTC
TTCTCCAT 
Cloning of AP2 into 
Pam 
BP-2b Not 
for 
CACCTGTCATGCGGCCGCGCTTTAGCTCTA
CCATCAGGA 
Cloning of BP-2b 
into Pam 
BP-2b Bgl 
rev 
CACCTGTCATAGATCTTTAAGAACGTAAAC
GACGACGA 
Cloning of BP-2b 
into Pam 
M-BP-
LPXTG-F 
AACAAAGGTACTGAGGGTATTGGTACAACA
ATTTTC 
Site-directed 
mutagenesis for 
LPXTG in BP-2b 
M-BP-
LPXTG-R 
CTCAGTACCTTTGTTATTTTCAACAGTTGG Site-directed 
mutagenesis for 
LPXTG in BP-2b 
M-BP-
E423-F 
GTAGTTGCGGCGAACGCGGGGTCTTA
TGAAGTAACT 
Site-directed 
mutagenesis for 
E423A in BP-2b 
M-BP-
E423-F 
AGACCCCGCGTTCGCCGCAACTACAG
AAGCAGATGG 
Site-directed 
mutagenesis for 
E423A in BP-2b 
M-BP-K77- CAAGGTGCGGAAGCTGAGTATAAAGC Site-directed 
mutagenesis for K77A 
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Table 3. Peptides used in this study 
 
PEPTIDE   SEQUENCE 
BP-2b = AP1-2b Dabsyl-KGTELPSTGGIGT-Edans 
AP2-2b Dabsyl-QTKGKLPFTGQV-Edans 
AP2-2a Dabsyl-SFLPKTGM-Edans 
AP2-1 Dabsyl-RGGLIPKTGEQQ-Edans 
	
 
 
F TTCAACTGAT in BP-2b 
M-BP-K77-
R 
AGCTTCCGCACCTTGAGGAATTAAATAAGAAG
CTCC  
Site-directed 
mutagenesis for K77A 
in BP-2b 
M-BP-K82-
F 
GAGTATGCGGCTTCAACTGATTTTAAT
TCTCTTTTT  
Site-directed 
mutagenesis for K82A 
in BP-2b 
M-BP-K82-
R 
TGAAGCCGCATACTCAGCTTCTTTACC
TTGAGGAAT 
Site-directed 
mutagenesis for K82A 
in BP-2b 
M-BP-
K118-F 
TGGGCTGCGTCTATATCAGCTAATAC
TACACCAGTT 
Site-directed 
mutagenesis for 
K118A in BP-2b 
M-BP-
K118-R 
TATAGACGCAGCCCATGTCGCAATCT
CATTTGCTGA 
Site-directed 
mutagenesis for 
K118A in BP-2b 
M-BP-
K175-F 
CATGAAGCGAATACTGATGCGACATG
GGGAGATGGT 
Site-directed 
mutagenesis for 
K175A in BP-2b 
M-BP-
K175-R 
AGTATTCGCTTCATGAATAGTAGCAT
TTGGAGTTAC 
Site-directed 
mutagenesis for 
K175A in BP-2b 
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Table 4.  Data collection and refinement statistics 
 
  SrtC1‐2b 
Wavelength 1.072 
Resolution range 45.92  - 1.95 (2.02  - 1.95) 
Space group P 21 21 2 
Unit cell 37.56 124.76 45.92 90 90 90 
Total reflections 56716 (5190) 
Unique reflections 16211 (1538) 
Multiplicity 3.5 (3.4) 
Completeness (%) 0.99 (0.96) 
Mean I/sigma(I) 15.73 (1.59) 
Wilson B-factor 34.81 
R-merge 0.04989 (0.6619) 
R-meas 0.0588 (0.7852) 
CC1/2 0.999 (0.695) 
CC* 1 (0.906) 
Reflections used in refinement 16202 (1534) 
Reflections used for R-free 811 (77) 
R-work1 0.1809 (0.2825) 
R-free2 0.2230 (0.3374) 
CC(work) 0.966 (0.836) 
CC(free) 0.973 (0.614) 
Number of non-hydrogen atoms 1645 
  macromolecules 1551 
  ligands 4 
Protein residues 193 
RMS(bonds) 0.008 
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RMS(angles) 1.03 
Ramachandran favored (%) 97 
Ramachandran allowed (%) 3.1 
Ramachandran outliers (%) 0 
Rotamer outliers (%) 0.57 
Clashscore 3.54 
Average B-factor 44.04 
  macromolecules 44.08 
  ligands 41.29 
  solvent 43.47 
Number of TLS groups 9 
 
Statistics for the highest-resolution shell are shown in parentheses. 
1 Rwork = Σ||F(obs)|- |F(calc)||/Σ|F(obs)| 
2 Rfree = as for Rwork, but calculated for 5.0% of the total reflections that were chosen at 
random and omitted from refinement. 
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Table 5.  Multiple structural alignment of SrtC1-2b (pdb 4d7w) with other known 
sortase structures using the DALI server  
 
 
Hits are ranked by Z-Score with best hits at the top of the table.  
PDB: Protein Data Bank  
rmsd: root-mean-square deviation of Cα atoms of superimposed proteins in Angstroms  
length alignment: number of structurally equivalent positions  
number of residues: number of structurally equivalent aligned residues  
sequence identity (%): percentage of amino acid identity in aligned positions  
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